<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins - Paravastu, SCV - 2016 | Cochrane Library</title> <meta content="Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins - Paravastu, SCV - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010878.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins - Paravastu, SCV - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010878.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010878.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins" name="citation_title"/> <meta content="Sharath Chandra Vikram Paravastu" name="citation_author"/> <meta content="The University of Sheffield" name="citation_author_institution"/> <meta content="sharathparavastu@googlemail.com" name="citation_author_email"/> <meta content="Margaret Horne" name="citation_author"/> <meta content="The University of Edinburgh Medical School" name="citation_author_institution"/> <meta content="P Dominic F Dodd" name="citation_author"/> <meta content="Northern General Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD010878.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/11/29" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010878.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010878.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010878.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Saphenous Vein [surgery]; Catheter Ablation [*methods]; Endovascular Procedures [*methods]; Laser Therapy [*methods]; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy [*methods]; Ultrasonography, Interventional [methods]; Varicose Veins [surgery, *therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010878.pub2&amp;doi=10.1002/14651858.CD010878.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="0TJL4CWK";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010878\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010878\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010878.pub2",title:"Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins",firstPublishedDate:"Nov 29, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010878.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010878.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010878.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010878.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010878.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010878.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010878.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010878.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010878.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010878.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5202 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010878.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-sec-0119"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-sec-0020"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-sec-0021"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-sec-0047"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-sec-0111"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/appendices#CD010878-sec-0124"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/table_n/CD010878StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/table_n/CD010878StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/information#CD010878-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Sharath Chandra Vikram Paravastu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/information#CD010878-cr-0003">Margaret Horne</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010878.pub2/information#CD010878-cr-0004">P Dominic F Dodd</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/information/en#CD010878-sec-0128">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 29 November 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010878.pub2">https://doi.org/10.1002/14651858.CD010878.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010878-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010878-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010878-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010878-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010878-abs-0001" lang="en"> <section id="CD010878-sec-0001"> <h3 class="title" id="CD010878-sec-0001">Background</h3> <p>Short (or small) saphenous vein (SSV) varices occur as a result of an incompetent sapheno‐popliteal junction, where the SSV joins the popliteal vein, resulting in reflux in the SSV; they account for about 15% of varicose veins. Untreated varicose veins may sometimes lead to ulceration of the leg, which is difficult to manage. Traditionally, treatment was restricted to surgery or conservative management. Since the 1990s, however, a number of minimally invasive techniques have been developed; these do not normally require a general anaesthetic, are day‐case procedures with a quicker return to normal activities and avoid the risk of wound infection which may occur following surgery. Nerve injury remains a risk with thermal ablation, but in cases where it does occur, the injury tends to be transient. </p> </section> <section id="CD010878-sec-0002"> <h3 class="title" id="CD010878-sec-0002">Objectives</h3> <p>To compare the effectiveness of endovenous laser ablation (EVLA), radiofrequency ablation (RFA) and ultrasound‐guided foam sclerotherapy (UGFS) versus conventional surgery in the treatment of SSV varices. </p> </section> <section id="CD010878-sec-0003"> <h3 class="title" id="CD010878-sec-0003">Search methods</h3> <p>The Cochrane Vascular Information Specialist searched the Specialised Register (last searched 17 March 2016) and the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 2). We searched clinical trials databases for details of ongoing or unpublished studies. </p> </section> <section id="CD010878-sec-0004"> <h3 class="title" id="CD010878-sec-0004">Selection criteria</h3> <p>We considered all randomised controlled trials (RCTs) comparing EVLA, endovenous RFA or UGFS with conventional surgery in the treatment of SSV varices for inclusion. </p> </section> <section id="CD010878-sec-0005"> <h3 class="title" id="CD010878-sec-0005">Data collection and analysis</h3> <p>We independently reviewed, assessed and selected trials that met the inclusion criteria; any disagreements were resolved by discussion. We extracted data and used the Cochrane's tool for assessing risk of bias. When the data permitted, we performed either fixed‐effect meta‐analyses with odds ratios (ORs) and 95% confidence intervals (CIs) or random‐effects meta‐analyses where there was moderate to significant heterogeneity. </p> </section> <section id="CD010878-sec-0006"> <h3 class="title" id="CD010878-sec-0006">Main results</h3> <p>We identified three RCTs, all of which compared EVLA with surgery; one also compared UGFS with surgery. There were no trials comparing RFA with surgery<i>.</i> The EVLA versus surgery comparison included 311 participants: 185 received EVLA and 126 received surgery. In the UGFS comparison, each treatment group contained 21 people. For several outcomes in the EVLA comparison, only a single study provided relevant data; as a result, the current review is limited in its ability to demonstrate meaningful results for some planned outcomes. The quality of evidence according to GRADE was moderate to low for the outcome measures in the EVLA versus surgery comparison, but low for the UGFS versus surgery comparison. Reasons for downgrading in the EVLA versus surgery comparison were risk of bias (for some outcomes, the outcome assessors were not blinded; and in one study the EVLA‐surgery allocation of 2:1 did not appear to be prespecified); imprecision (data were only available from a single small study and the CIs were relatively wide); indirectness (one trial reported results at six months rather than one year and was inadequately powered for SSV varices‐only analysis). Reasons for downgrading in the UGFS versus surgery comparison were imprecision (only one trial offered UGFS and several participants were missing from the analysis) and a limitation in design (the study was inadequately powered for SSV participants alone). </p> <p>For the EVLA versus surgery comparison, recanalisation or persistence of reflux at six weeks occurred less frequently in the EVLA group than in the surgery group (OR 0.07, 95% CI 0.02 to 0.22; I<sup>2</sup> = 51%; 289 participants, 3 studies, moderate‐quality evidence). Recurrence of reflux at one year was also less frequent in the EVLA group than in the surgery group (OR 0.24, 95% CI 0.07 to 0.77; I<sup>2</sup> = 0%; 119 participants, 2 studies, low‐quality evidence). For the outcome clinical evidence of recurrence (i.e. presence of new visible varicose veins) at one year, there was no difference between the two treatment groups (OR 0.54, 95% CI 0.17 to 1.75; 99 participants, 1 study, low‐quality evidence). Four participants each in the EVLA and surgery groups required reintervention due to technical failure (99 participants, 1 study, moderate‐quality evidence). There was no difference between the two treatment groups for disease‐specific quality of life (QoL) (Aberdeen Varicose Veins Questionnaire) either at six weeks (mean difference (MD) 0.15, 95% CI ‐1.65 to 1.95; I<sup>2</sup> = 0%; 265 participants, 2 studies, moderate‐quality evidence), or at one year (MD ‐1.08, 95% CI ‐3.39 to 1.23; 99 participants, 1 study, low‐quality evidence). Main complications reported at six weeks were sural nerve injury, wound infection and deep venous thrombosis (DVT) (one DVT case in each treatment group; EVLA: 1/161, 0.6%; surgery 1/104, 1%; 265 participants, 2 studies, moderate‐quality evidence). </p> <p>For the UGFS versus surgery comparison, there were insufficient data to detect clear differences between the two treatment groups for the two outcomes recanalisation or persistence of reflux at six weeks (OR 0.34, 95% CI 0.06 to 2.10; 33 participants, 1 study, low‐quality evidence), and recurrence of reflux at one year (OR 1.19, 95% CI 0.29 to 4.92; 31 participants, 1 study, low‐quality evidence). No other outcomes could be reported for this comparison because the study data were not stratified according to saphenous vein. </p> </section> <section id="CD010878-sec-0007"> <h3 class="title" id="CD010878-sec-0007">Authors' conclusions</h3> <p>Moderate‐ to low‐quality evidence exists to suggest that recanalisation or persistence of reflux at six weeks and recurrence of reflux at one year are less frequent when EVLA is performed, compared with conventional surgery. For the UGFS versus conventional surgery comparison, the quality of evidence is assessed to be low; consequently, the effectiveness of UGFS compared with conventional surgery in the treatment of SSV varices is uncertain. Further RCTs for all comparisons are required with longer follow‐up (at least five years). In addition, measurement of outcomes such as recurrence of reflux, time taken to return to work, duration of procedure, pain, etc., and choice of time points during follow‐up should be standardised such that future trials evaluating newer technologies can be compared efficiently. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010878-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010878-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010878-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010878-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010878-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010878-abs-0003" lang="en"> <h3>Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus open surgery for the treatment of short saphenous varicose veins </h3> <p><b>Background</b> </p> <p>Varicose veins (varices) are enlarged veins occurring below the skin's surface, usually in the legs. One‐third of the UK population may be affected. They can be painful and itchy, the surrounding skin may change colour, and occasionally they may bleed; in some people, untreated varicose veins may lead to ulceration. Varicose veins occur due to leaky valves within the veins. Traditionally, they were treated with surgery to remove the veins. Newer techniques require neither vein removal, nor a general anaesthetic; they may involve less pain after the procedure and have a lower risk of complications, resulting in quicker recovery and return to normal activities. Endovenous laser ablation (EVLA) and radiofrequency ablation (RFA) are methods that seal the main leaking vein. They are performed using a local anaesthetic; a probe is passed into the vein: either a tiny laser or radiofrequency makes the wall of the vein heat up causing the vein to clot off and seal. With ultrasound‐guided foam sclerotherapy (UGFS), a foam is injected into the veins; the foam pushes the blood away, causing thickening and scarring of the inside of the vein so that it becomes blocked. </p> <p><b>Study characteristics and key results</b> </p> <p>We searched for all randomised controlled trials to March 2016 that compared at least one of the newer techniques with surgery, when treating short saphenous vein (SSVs; found in the lower leg) varices. We found three trials comparing EVLA with surgery; one trial compared UGFS with surgery, but none reported RFA. The main measures (outcomes) were recanalisation (blood flowing in the veins again) or persistence of reflux (due to failure of treatment) at six weeks; recurrence of reflux at one year; clinical evidence of recurrence (presence of new varicose veins) at one year; repeat treatment due to failure; quality of life (QoL) at six weeks and one year after the treatment; and complications after treatment. </p> <p>The EVLA versus surgery comparison included 311 participants: 185 received EVLA and 126 received surgery. In the UGFS comparison, each treatment group contained 21 people. For several outcomes in the EVLA comparison, only one study provided data; consequently, this review has limited ability to demonstrate meaningful results for some planned outcomes. </p> <p>EVLA versus surgery: there was less recanalisation or persistence of reflux at six weeks and less recurrence of reflux at one year in the EVLA group; however, there were insufficient data to report clear differences in clinical recurrence at one year. One trial reported four participants in each group required further treatment. There was no difference between treatments in QoL. Although some participants had postoperative complications (e.g., sural nerve injury (the sural nerve is in the calf), infection, deep venous thrombosis (DVT; blood clots in veins), inflammation of the wall of the vein), most complications improved without treatment and the two cases of DVT resolved after treatment with medicines. </p> <p>UGFS versus surgery: there were insufficient data to detect clear differences between treatment groups for recanalisation or persistence of reflux at six weeks and recurrence of reflux at one year. Data were not available for other outcomes. </p> <p><b>Quality of the evidence</b> </p> <p>For the EVLA comparison, the quality of evidence was moderate for recanalisation or persistence of reflux, QoL and complications, all at six weeks, and retreatment due to technical failure, but low for recurrence of reflux, QoL and clinical evidence of recurrence after one year. The quality of evidence was downgraded due to imprecision (small number of trials with few participants) and bias (outcome assessors aware of treatment allocation in some studies and one study recruited insufficient participants with SSV). For the UGFS comparison, evidence was low quality because one study (with few participants with SSV) offered UGFS and several participants were missing from the analysis. </p> <p>The main difficulty with this review was lack of data: we found a small number of trials and two trials had substantial amounts of unavailable data. Further well‐designed studies are needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010878-sec-0119" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010878-sec-0119">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010878-sec-0160">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010878-sec-0119"></div> <h3 class="title" id="CD010878-sec-0120">Implications for practice</h3> <section id="CD010878-sec-0120"> <p>Low‐ to moderate‐quality evidence exists to suggest that recanalisation or persistence of reflux at six weeks and recurrence of reflux at one year are less frequent when endovenous laser ablation (EVLA) is performed, compared with conventional open surgery. For the ultrasound‐guided foam sclerotherapy (UGFS) versus conventional surgery comparison, we assessed the quality of evidence as low; consequently, the effectiveness of UGFS compared with conventional surgery in the treatment of short saphenous vein (SSV) varices is uncertain. </p> </section> <h3 class="title" id="CD010878-sec-0121">Implications for research</h3> <section id="CD010878-sec-0121"> <p>The objective of this review was to compare the effectiveness of EVLA, radiofrequency ablation (RFA) and UGFS with conventional surgery in the treatment of SSV varices. However, because we found no trials that reported RFA, it has only been possible to report and analyse the results of two of these comparisons (one of which, UGFS, was only reported in a single small trial). </p> <p>Although this review included three studies, they each contained a relatively small number of participants. To compound this difficulty, one study did not present their results stratified by type of saphenous vein and as a consequence most outcomes relating to quality of life, pain and return to work for people with SSV varices have not been reported, and a second study has so far only reported six weeks' follow‐up. As a result, statistical analyses of certain prespecified outcomes in this review could not be undertaken since, in several instances, only one study could be evaluated. Furthermore, since different measures were used to record certain outcomes such as pain and return to work, it precluded the pooling of results in meta‐analysis. </p> <p>Continued research with well‐designed randomised controlled trials (RCTs) comparing minimally invasive endovenous procedures with conventional surgery in the treatment of SSV varices is required. In particular, future trials should aim to extend the follow‐up period to a minimum of two years and ideally five years or longer, as there is a hint in one study that for some of the minimally invasive endovenous procedures, the rate of reflux recurrence over time might be similar to or even higher than the recurrence rate for surgery over the same time period. In addition, there should be a standardisation of definitions in future work: for example, as discussed above, the three studies in this review used different thresholds in the definition of reflux (see <a href="#CD010878-sec-0117">Potential biases in the review process</a>). Although it is not possible to blind participants and trial personnel to the interventional treatment allocated, when designing future RCTs consideration should be given to blinding outcome assessors or using independent outcome assessors rather than the clinician who performed the intervention. However, one researcher noted that future recruitment to a new RCT that compares minimally invasive endovenous procedures with open surgery may be more difficult, because clinical equipoise has become rarer as more research has been conducted (Nandhra 2015 in <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>). Future trials evaluating other minimally invasive techniques such as mechanico‐chemical ablation and VenaSeal™ glue where tumescent anaesthesia is not required might provide more evidence on the effective treatment of SSV varices. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010878-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010878-sec-0015"></div> <div class="table" id="CD010878-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Endovenous laser ablation compared to conventional surgery for short saphenous vein varices</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Endovenous laser ablation compared to conventional surgery for short saphenous vein varices </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people requiring intervention for short saphenous vein varices </p> <p><b>Setting:</b> hospital day‐case vascular surgery department </p> <p><b>Intervention:</b> EVLA </p> <p><b>Comparison:</b> conventional surgery </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conventional surgery</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with EVLA</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Recanalisation or persistence of reflux at 6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.07<br/> (0.02 to 0.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>289<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1000<br/> (7 to 68) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Recurrence of reflux at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.24<br/> (0.07 to 0.77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>119<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>242 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000<br/> (22 to 197) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical evidence of recurrence after 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.54<br/> (0.17 to 1.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>176 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>104 per 1000<br/> (35 to 273) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reintervention (due to technical failure)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 participants in EVLA group required further treatment: 1 had second EVLA, 3 UGFS</p> <p>4 participants in surgery group required further treatment: 3 had EVLA, 1 ultrasound‐guided perforator ligation </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific QoL (AVVQ) at 6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease‐specific QoL (AVVQ) at 6 weeks was 8.75</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease‐specific QoL at 6 weeks was 8.95</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>265<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference between the disease‐specific QoL (AVVQ) in both groups at 6 weeks was 0.15 (‐1.65 to 1.95). (AVVQ range: 0 = no impact on QoL; 100 = greatest possible impact on QoL) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific QoL (AVVQ) at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease‐specific QoL (AVVQ) at 1 year was 5.3</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease‐specific QoL (AVVQ) at 1 year was 4.22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference between the disease‐specific QoL (AVVQ) at 1 year in both groups was ‐1.08 (‐3.39 to 1.23). (AVVQ range: 0 = no impact on QoL; 100 = greatest possible impact on QoL) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Complications at 6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>265</p> <p>(2 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Main complications reported were sural nerve injury at 6 weeks (11/161 EVLA; 30/104 surgery), wound infection; 2 cases of DVT (1e in each group). See <a href="#CD010878-tbl-0006">Table 4</a> for detailed information </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AVVQ:</b> Aberdeen Varicose Veins Questionnaire; <b>CI:</b> confidence interval; <b>EVLA:</b> endovenous laser ablation; <b>OR:</b> odds ratio; <b>QoL:</b> quality of life; <b>RCT:</b> randomised controlled trial; <b>UGFS:</b> ultrasound‐guided foam sclerotherapy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to risk of bias: limitation of power in one study, and a 2:1 EVLA:surgery allocation that did not appear to be prespecified in another study.<br/> <sup>2</sup> Downgraded one level due to risk of bias and one level for potential concerns relating to imprecision and indirectness, since one study reported outcomes at six months rather than one year.<br/> <sup>3</sup> Downgraded one level for risk of bias and one level for imprecision (n = 99).<br/> <sup>4</sup> Downgraded one level for imprecision (n = 99).<br/> <sup>5</sup> Downgraded one level for risk of bias. Decision taken not to downgrade for imprecision because the mean difference between the two treatments was negligible on the total AVVQ range (0 to 100).<br/> <sup>6</sup> Downgraded one level for imprecision in one study. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010878-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Ultrasound‐guided foam sclerotherapy compared to conventional surgery for short saphenous vein varices</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Ultrasound‐guided foam sclerotherapy compared to conventional surgery for short saphenous vein varices </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people requiring intervention for short saphenous vein varices </p> <p><b>Setting:</b> hospital day‐case vascular surgery department </p> <p><b>Intervention:</b> UGFS </p> <p><b>Comparison:</b> conventional surgery </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conventional surgery</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with UGFS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Recanalisation or persistence of reflux at 6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.34<br/> (0.06 to 2.10) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>33<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>294 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>124 per 1000<br/> (24 to 467) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Recurrence of reflux at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.19<br/> (0.29 to 4.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>31<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Follow‐up for this outcome was only available for 6 months in this trial</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>429 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>472 per 1000<br/> (179 to 787) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical evidence of recurrence after 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical evidence not stratified by GSV/SSV</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reintervention (due to technical failure)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reintervention not stratified by GSV/SSV</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific QoL (AVVQ) at 6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>QoL not stratified by GSV/SSV</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific QoL (AVVQ) at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>QoL not stratified by GSV/SSV</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Complications at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Complications not stratified by GSV/SSV</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AVVQ:</b> Aberdeen Varicose Veins Questionnaire; <b>CI:</b> confidence interval; <b>GSV:</b> great saphenous vein; <b>OR:</b> odds ratio; <b>QoL:</b> quality of life; <b>RCT:</b> randomised controlled trial; <b>SSV:</b> short saphenous vein; <b>UGFS:</b> ultrasound‐guided foam sclerotherapy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for imprecision (only one trial in this review offered UGFS) and one level for limitation in design as the study was inadequately powered for participants with SSV varices alone. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010878-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010878-sec-0016">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010878-sec-0137">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD010878-sec-0016"></div> <section id="CD010878-sec-0017"> <h3 class="title" id="CD010878-sec-0017">Description of the condition</h3> <p>Abnormally dilated veins are termed varicose veins (varices). They are commonly noted in the lower limbs and may be seen either as dilated and tortuous veins or as palpable veins under the skin. Approximately one‐third of the population in the UK is affected by varicose veins (<a href="./references#CD010878-bbs2-0043" title="National Institute for Health and Care Excellence. Varicose veins in the legs. The diagnosis and management of varicose veins [CG168], 2013. www.nice.org.uk/nicemedia/live/14226/64566/64566.pdf (accessed 14 August 2013). ">NICE 2013</a>). </p> <p>Varicose veins predominantly occur as a result of either an incompetent sapheno‐femoral junction, where the great (long) saphenous vein (GSV) joins the femoral vein, or an incompetent sapheno‐popliteal junction (SPJ), where the short (small) saphenous vein (SSV) joins the popliteal vein. Incompetence of the sapheno‐femoral junction leads to reflux in the GSV and incompetence in the SPJ leads to reflux in the SSV. Approximately 15% of varicose veins are due to SSV reflux (<a href="./references#CD010878-bbs2-0030" title="AlmgrenB , ErikssonI . Valvular incompetence in superficial, deep and perforator veins of limbs with varicose veins. Acta Chirugica Scandinavica1990;156(1):69‐74. ">Almgren 1990</a>). </p> <p>In addition to the obvious finding of abnormally dilated veins, participants with varicose veins may present with a variety of symptoms such as pain, itching and skin changes. Untreated varicose veins in some of these participants may lead to ulceration, which is difficult to manage. </p> <p>Varicose veins due to SSV incompetence are traditionally managed by a conventional surgical procedure, where an incision is made in the popliteal fossa, and the SSV and SPJ are identified. The SPJ is then disconnected and a short segment of the SSV is either resected or stripped. Two‐thirds of surgeons in the UK perform conventional surgery on the SPJ as described; however, some variations do exist (<a href="./references#CD010878-bbs2-0050" title="WinterbornRJ , CampbellWB , HeatherBP , EarnshawJJ . The management of short saphenous varicose veins: a survey of the members of the vascular surgical society of Great Britain and Ireland. European Journal of Vascular and Endovascular Surgery2004;28(4):400‐3. ">Winterborn 2004</a>). Although this procedure is considered the gold standard, there is a complication rate of 5% (<a href="./references#CD010878-bbs2-0050" title="WinterbornRJ , CampbellWB , HeatherBP , EarnshawJJ . The management of short saphenous varicose veins: a survey of the members of the vascular surgical society of Great Britain and Ireland. European Journal of Vascular and Endovascular Surgery2004;28(4):400‐3. ">Winterborn 2004</a>), and associated risks such as recurrence and disabling nerve injury make this surgery challenging (<a href="./references#CD010878-bbs2-0046" title="SamRC , SilvermanSH , BradburyAW . Nerve injuries and varicose vein surgery. European Journal of Vascular and Endovascular Surgery2004;27(2):113‐20. ">Sam 2004</a>). </p> </section> <section id="CD010878-sec-0018"> <h3 class="title" id="CD010878-sec-0018">Description of the intervention</h3> <p>Since the 1990s, minimally invasive techniques have been developed to treat sapheno‐femoral junction and GSV incompetence. These include endovenous laser ablation (EVLA), radiofrequency ablation (RFA) and ultrasound‐guided foam sclerotherapy (UGFS). These techniques have been extensively used in the treatment of sapheno‐femoral junction and GSV reflux (<a href="./references#CD010878-bbs2-0042" title="NesbittC , BedenisR , BhattacharyaV , StansbyG . Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database of Systematic Reviews2014, Issue 7. [DOI: 10.1002/14651858.CD005624.pub3] ">Nesbitt 2014</a>; <a href="./references#CD010878-bbs2-0045" title="RigbyKA , PalfreymanSSJ , BeverleyC , MichaelsJA . Surgery versus sclerotherapy for the treatment of varicose veins. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD004980] ">Rigby 2009</a>), and the National Institute for Health and Care Excellence (NICE) clinical guideline considers them safe in the management of varicose veins (<a href="./references#CD010878-bbs2-0043" title="National Institute for Health and Care Excellence. Varicose veins in the legs. The diagnosis and management of varicose veins [CG168], 2013. www.nice.org.uk/nicemedia/live/14226/64566/64566.pdf (accessed 14 August 2013). ">NICE 2013</a>). </p> <p> <ul id="CD010878-list-0001"> <li> <p>In EVLA, under ultrasound guidance, a bare‐tipped or jacketed laser optical fibre is inserted into the vein from a distal point towards the junction, gentle pressure applied over the vein and the laser activated. This results in heat coagulation of the blood in the vein. The fibre is then slowly withdrawn and the vein becomes occluded. </p> </li> <li> <p>In RFA, under ultrasound guidance, a catheter electrode is inserted into the vein and the tip placed close to the junction. When activated, heat generated from the electrode results in closure of the vein. </p> </li> <li> <p>In UGFS, a sclerosant agent turned into foam is injected into the affected vein, where the foam displaces the blood. The irritant nature of the sclerosant causes inflammation of the endothelium and sub‐endothelium layers of the vein wall, resulting in fibrosis and occlusion of the vein. </p> </li> </ul> </p> <p>EVLA and RFA are day‐case procedures and performed under tumescent local anaesthesia, where local anaesthetic is injected around the vein, along the length of intervention. UGFS is also a day‐case procedure and does not require any anaesthesia. Patients are allowed to ambulate immediately following the procedure and are discharged within hours of treatment. Furthermore, the risks of wound infection and nerve injury may be abated or significantly reduced due to the mode of these interventions. </p> </section> <section id="CD010878-sec-0019"> <h3 class="title" id="CD010878-sec-0019">Why it is important to do this review</h3> <p>In addition to the known risks of conventional surgery, there is concern about its success in dealing with SPJ and SSV reflux. One review comparing treatment for SSV varices showed variation in the success rate of conventional surgery, which ranged between 24% and 100% (<a href="./references#CD010878-bbs2-0048" title="TellingsSS , CeulenRP , SommerA . Surgery and endovenous techniques for the treatment of small saphenous varicose veins: a review of the literature. Phlebology2011;26(5):179‐84. ">Tellings 2011</a>). Therefore, it is important to explore the alternative treatment modalities, such as EVLA, RFA or UGFS, which are now commonly used in the management of GSV varices. The <a href="./references#CD010878-bbs2-0048" title="TellingsSS , CeulenRP , SommerA . Surgery and endovenous techniques for the treatment of small saphenous varicose veins: a review of the literature. Phlebology2011;26(5):179‐84. ">Tellings 2011</a> review included non‐randomised, heterogeneous studies; however, it did show that minimally invasive techniques tend to have a higher success rate compared to conventional surgery. </p> <p>EVLA and RFA have been shown to be as effective as conventional surgery in the management of GSV varices (<a href="./references#CD010878-bbs2-0042" title="NesbittC , BedenisR , BhattacharyaV , StansbyG . Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database of Systematic Reviews2014, Issue 7. [DOI: 10.1002/14651858.CD005624.pub3] ">Nesbitt 2014</a>). However, their role in the management of SSV varices has not been thoroughly evaluated. The outcomes of this review, which will assess the role of EVLA, RFA and UGFS, will be useful in clinical decision‐making. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010878-sec-0020" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010878-sec-0020">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010878-sec-0141">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010878-sec-0020"></div> <p>To compare the effectiveness of endovenous laser ablation (EVLA), radiofrequency ablation (RFA) and ultrasound‐guided foam sclerotherapy (USFS) versus conventional surgery in the treatment of SSV varices. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010878-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010878-sec-0021">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010878-sec-0142">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010878-sec-0021"></div> <section id="CD010878-sec-0022"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010878-sec-0023"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) comparing EVLA or RFA or UGFS with conventional surgery in the treatment of SSV varices. We accepted all published RCTs and presumed operator competence, unless defined in the article as a learning‐curve report. </p> </section> <section id="CD010878-sec-0024"> <h4 class="title">Types of participants</h4> <p>We included men and women aged 18 years and over who received treatment for SSV varices.</p> </section> <section id="CD010878-sec-0025"> <h4 class="title">Types of interventions</h4> <section id="CD010878-sec-0026"> <h5 class="title">Interventions</h5> <p> <ul id="CD010878-list-0002"> <li> <p>Endovenous laser ablation therapy (EVLA).</p> </li> <li> <p>Endovenous radiofrequency ablation (RFA).</p> </li> <li> <p>Ultrasound‐guided foam sclerotherapy (UGFS).</p> </li> </ul> </p> </section> <section id="CD010878-sec-0027"> <h5 class="title">Comparator</h5> <p> <ul id="CD010878-list-0003"> <li> <p>Conventional surgery.</p> </li> </ul> </p> </section> </section> <section id="CD010878-sec-0028"> <h4 class="title">Types of outcome measures</h4> <section id="CD010878-sec-0029"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010878-list-0004"> <li> <p>Recanalisation or persistence of reflux at six weeks.</p> </li> <li> <p>Recurrence of reflux at one year.</p> </li> </ul> </p> <p>We considered persistence of reflux at six weeks after the procedure as being due to technical failure of the intervention. We used duplex ultrasound (DUS) reflux of greater than 0.5 seconds as the definition for reflux. </p> <p> <ul id="CD010878-list-0005"> <li> <p>Clinical evidence of recurrence (i.e. presence of new visible varicose veins).</p> </li> </ul> <ul id="CD010878-list-0006"> <li> <p>Reintervention (due to technical failure).</p> </li> </ul> </p> <p>We considered failure to obliterate as technical failure and not as recurrence, and any intervention to deal with this as reintervention. </p> <p>We distinguished between further treatment of the SSV and adjuvant tributary treatment (e.g. delayed phlebectomy). </p> </section> <section id="CD010878-sec-0030"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010878-list-0007"> <li> <p>Quality of life (QoL, determined by pre‐ and postprocedure QoL scores).</p> </li> <li> <p>Postoperative pain.</p> </li> </ul> </p> <p>We assessed pain using either visual analogue scale (VAS) scores, postoperative analgesia requirements or participant complaints, as reported by the trialists. </p> <p> <ul id="CD010878-list-0008"> <li> <p>Complications (such as postprocedural deep venous thrombosis (DVT), thermal injury, sural nerve injury, wound infection, haematoma, pigmentation or skin bruising, and phlebitis). </p> </li> </ul> </p> <p>We regarded postoperative cutaneous injury or sural nerve injury as thermal‐related injuries. </p> <p> <ul id="CD010878-list-0009"> <li> <p>Healing of ulcers.</p> </li> <li> <p>Hospital stay.</p> </li> <li> <p>Return to work.</p> </li> </ul> </p> <p>In addition, we reported on the type of anaesthesia and the duration of the procedure, if these data were available. </p> </section> </section> </section> <section id="CD010878-sec-0031"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010878-sec-0032"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Vascular Information Specialist (CIS) searched the Specialised Register (March 2016). In addition, the CIS searched the Cochrane Register of Studies (CRS) (<a href="http://www.metaxis.com/CRSWeb/Index.asp" target="_blank">www.metaxis.com/CRSWeb/Index.asp</a>) (Cochrane Central Register of Controlled Trials (CENTRAL) (2016, Issue 2)). See <a href="./appendices#CD010878-sec-0125">Appendix 1</a> for details of the search strategy used to search the CRS. The Specialised Register is maintained by the CIS and is constructed from weekly electronic searches of MEDLINE, Embase, CINAHL and AMED, and through handsearching relevant journals. The full list of the databases, journals and conference proceedings which have been searched, as well as the search strategies used, are described in the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PVD/frame.html" target="_blank">Specialised Register</a> section of the Cochrane Vascular module in the Cochrane Library (<a href="http://www.cochranelibrary.com/" target="_blank">www.cochranelibrary.com</a>). </p> <p>The CIS searched the following trial databases for details of ongoing and unpublished studies using the terms in <a href="./appendices#CD010878-sec-0126">Appendix 2</a>: </p> <p> <ul id="CD010878-list-0010"> <li> <p>World Health Organization International Clinical Trials Registry (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>); </p> </li> <li> <p>ISRCTN Register (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com/</a>). </p> </li> </ul> </p> </section> <section id="CD010878-sec-0033"> <h4 class="title">Searching other resources</h4> <p>We scrutinised the reference lists of relevant articles retrieved by the electronic searches for additional citations. </p> <p>In addition, we checked reference lists in published reviews on varicose veins, and various health services research‐related resources via the internet. These included health economics and health technology assessment (HTA) organisations and guideline‐producing agencies: NICE (<a href="http://guidance.nice.org.uk/" target="_blank">guidance.nice.org.uk/</a>) and the Scottish Intercollegiate Guidelines Network (SIGN) (<a href="http://www.sign.ac.uk/guidelines/index.html" target="_blank">www.sign.ac.uk/guidelines/index.html</a>). Further, we sought trial reports through examination of the proceedings from the following meetings: </p> <p> <ul id="CD010878-list-0011"> <li> <p>Vascular Society of Great Britain and Ireland (2005, 2007 to 2014);</p> </li> <li> <p>Association of Surgeons of Great Britain and Ireland (2003 to 2015);</p> </li> <li> <p>British Society of Interventional Radiology (2007 to 2015);</p> </li> <li> <p>American Venous Forum (2007 to 2016);</p> </li> <li> <p>The Society for Vascular Surgery (2009 to 2015);</p> </li> <li> <p>European Society for Vascular Surgery (2007), and contents pages of all issues of the European Journal of Vascular and Endovascular Surgery (January 2003 to April 2016). </p> </li> </ul> </p> </section> </section> <section id="CD010878-sec-0034"> <h3 class="title" id="CD010878-sec-0034">Data collection and analysis</h3> <section id="CD010878-sec-0035"> <h4 class="title">Selection of studies</h4> <p>Two review authors (SP and MH) independently evaluated trials for inclusion. Any disagreements were resolved by discussion. </p> </section> <section id="CD010878-sec-0036"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (SP and MH) independently extracted data using a proforma designed by Cochrane Vascular. Any disagreements were resolved by discussion. </p> </section> <section id="CD010878-sec-0037"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (SP and MH) independently assessed the quality of the included studies by using Cochrane's 'Risk of bias' tool (<a href="./references#CD010878-bbs2-0035" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). This tool provides a standard protocol for allowing judgements to be made on sequence generation, allocation methods, blinding, incomplete outcome data, selective outcome reporting and any other relevant biases. For each of these six items, we assessed the risk of bias as 'low risk', 'high risk' or 'unclear risk', with the 'unclear risk' of bias indicating either a lack of information or uncertainty over the potential for bias. Any disagreements were resolved by discussion with the Managing Editor of Cochrane Vascular. </p> </section> <section id="CD010878-sec-0038"> <h4 class="title">Measures of treatment effect</h4> <p>We used odds ratio (OR) and 95% confidence interval (CI) as the measure of treatment effect for each dichotomous outcome. Where there were sufficient data, we calculated a summary statistic for each outcome using either a fixed‐effect or random‐effects model. We analysed continuous scales of measurement in continuous form (i.e. mean difference, MD) and 95% CI. </p> </section> <section id="CD010878-sec-0039"> <h4 class="title">Unit of analysis issues</h4> <p>For all outcomes, we considered each individual participant as the unit of analysis.</p> </section> <section id="CD010878-sec-0040"> <h4 class="title">Dealing with missing data</h4> <p>Where possible, we carried out analysis on an intention‐to‐treat (ITT) basis. In cases of incomplete or missing data from trials, we contacted the trialists for the required information. Where such an attempt to obtain information was unsuccessful, we presented the available data without undertaking meta‐analysis. </p> </section> <section id="CD010878-sec-0041"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity in the data and cautiously explored it using the characteristics of the studies, particularly assessments of quality. We used the I<sup>2</sup> statistic to assess heterogeneity with an I<sup>2</sup> value of 25% to 50% indicating low heterogeneity, 50% to 75% moderate heterogeneity and greater than 75% significant heterogeneity. </p> </section> <section id="CD010878-sec-0042"> <h4 class="title">Assessment of reporting biases</h4> <p>We intended to test for publication bias using funnel plots if we included more than 10 studies in the review (<a href="./references#CD010878-bbs2-0035" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD010878-sec-0043"> <h4 class="title">Data synthesis</h4> <p>Where direct comparisons could be made, we presented data as OR or MD. We examined studies for heterogeneity and used a random‐effects model in case of significant heterogeneity (I<sup>2</sup> &gt; 75%); otherwise we used a fixed‐effect model. We presented data that could not be pooled in tabular form. We performed statistical analyses according to the statistical guidelines for reviews outlined in Cochrane Vascular's module using Review Manager 5 (<a href="./references#CD010878-bbs2-0044" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD010878-sec-0044"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We intended to analyse foam sclerotherapy as a generic procedure unless we identified significant differences between trials reporting outcomes for different agents. In such a case, we planned to perform a subgroup analysis. </p> <p>For EVLA, we planned to perform a subgroup analysis of 800 nm to 980 nm versus 1000 nm to 1500 nm wavelengths, if sufficient data were available. </p> <p>We also planned to note optical fibre tip data and to perform a subgroup analysis if sufficient data were available. </p> </section> <section id="CD010878-sec-0045"> <h4 class="title">Sensitivity analysis</h4> <p>If any trials were judged to be of high risk of bias, we planned to perform a sensitivity analysis to assess outcomes with and without the trials that were of high risk of bias. </p> <p>If participants in some of the identified trials had undergone simultaneous treatment for both SSV as well as GSV incompetence, we planned to perform a sensitivity analysis (where possible) excluding such participants. </p> <p>We planned to undertake sensitivity analyses by excluding those studies that were not adequately powered (e.g. if a trial included participants with GSV varices or SSV varices or both, then only the subset of those recruited to the trial who had SSV varices would be included in this review, whereas the estimated sample‐size calculation for adequate power would be based on the inclusion of all participants). </p> <section id="CD010878-sec-0046"> <h5 class="title">'Summary of findings' tables</h5> <p>We used the GRADE approach to interpret findings (<a href="./references#CD010878-bbs2-0037" title="LangendamM , AklEA , DahmP , GlasziouP , GuyattG , SchünemannHJ . Assessing and presenting summaries of evidence in Cochrane Reviews. Systematic Reviews2013;2:81. ">Langendam 2013</a>), and for each comparison we presented the seven main outcomes of the review, using the GRADEpro GDT software (<a href="./references#CD010878-bbs2-0034" title="GRADEproGDT . GRADEpro Guideline Development Tool (GRADEpro GDT). Hamilton (ON): GRADE Working Group, McMaster University, 2015. ">GRADEpro GDT 2015</a>). We included the following outcomes in the 'Summary of findings' tables: recanalisation or persistence of reflux at six weeks; recurrence of reflux at one year; clinical evidence of recurrence at one year; reintervention (due to technical failure); disease‐specific QoL (Aberdeen Varicose Veins Questionnaire, AVVQ) at six weeks and one year; and complications at six weeks. For each outcome, the quality of the evidence was graded as high, moderate, low or very low; RCTs were graded as high‐quality evidence, and then downgraded by one level for each of the following factors that were present: limitations in the study design and implementation, indirectness of evidence, unexplained heterogeneity or inconsistency of results, imprecision of results and high probability of publication bias (<a href="./references#CD010878-bbs2-0033" title="GRADE Working Group 2004. Grading quality of evidence and strength of recommendations. BMJ2004;328:1490‐4. ">GRADE Working Group 2004</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010878-sec-0047" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010878-sec-0047"></div> <section id="CD010878-sec-0048"> <h3 class="title">Description of studies</h3> <section id="CD010878-sec-0049"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD010878-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD010878-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010878-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>After removing duplicates, the review authors initially screened 128 records by reviewing their title and abstract; we removed 78 records as they were not relevant and downloaded, read and assessed the full text of 50 records for eligibility. At this stage, we excluded 25 studies (37 records) (see <a href="./references#CD010878-bbs1-0002" title="">Excluded studies</a> and <a href="./references#CD010878-sec-0135" title="">Characteristics of excluded studies</a> for reasons for exclusion of the study). We included three studies (12 records) in the qualitative/quantitative analysis (see <a href="./references#CD010878-bbs1-0001" title="">Included studies</a> for a list of the records attached to each study, and <a href="./references#CD010878-sec-0134" title="">Characteristics of included studies</a> for a summary of each study). One study is awaiting classification, as we were unable to locate the paper. </p> <p>Screening of health economics and HTA organisations, guideline‐producing agencies (NICE and SIGN) and proceedings of conferences for relevant abstracts did not result in any additional reports. </p> </section> <section id="CD010878-sec-0050"> <h4 class="title">Included studies</h4> <p>Three studies fulfilled the necessary criteria for inclusion in this review (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>). See <a href="./references#CD010878-sec-0134" title="">Characteristics of included studies</a> table for a summary of each study and an assessment of the risk of bias. All three studies were prospective RCTs: one recruited from a single UK hospital (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>), one from two hospitals in the Netherlands (<a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>), and one from 11 hospitals in the UK (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>) (although only eight centres offered EVLA, so the EVLA versus surgery comparison was restricted to recruitment from these eight centres). Recruitment periods for the three studies ranged from October 2005 to October 2012. </p> <p>Two studies solely recruited participants with SSV varices (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>), whereas <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> recruited participants with GSV varices, SSV varices, or a combination of GSV and SSV varices. All three studies compared EVLA with conventional surgery, and <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> compared UGFS with surgery. <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> also compared UGFS with EVLA, but this comparison is not part of this review. No studies compared endovenous RFA with surgery. </p> <p>The total number of participants included in the EVLA versus conventional surgery comparison was 311: 185 underwent EVLA and 126 underwent surgery. <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> allocated 53 participants to EVLA and 53 participants to surgery; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> used a 2:1 allocation, with 118 participants undergoing EVLA and 57 undergoing surgery. In <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>, 14 participants with SSV varices underwent EVLA and 16 underwent surgery in the eight‐hospital comparison. For the UGFS versus surgery comparison (in the 11‐centre <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study), there were 21 participants in each group. </p> <p>The primary outcome measure for two studies was early technical success. This was defined in <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> as the abolition of SSV reflux due to SPJ incompetence at six weeks after the procedure on DUS assessment (and reflux was defined as a retrograde flow of 1 second or more on spectral Doppler after augmentation); <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> used thresholds of greater than 0.5 seconds to define incompetence of the superficial venous system (greater than 0.8 seconds in the case of deep veins). <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> reported early technical success as a secondary outcome. <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> defined reflux as greater than 1 second on DUS. <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> also recorded clinical evidence of recurrence. </p> <p>The primary outcome measures for the third study (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>) examined QoL at six months after treatment; participants completed three different questionnaires, one of which was disease‐specific, and the other two were generic QoL. <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> reported results from the same three questionnaires as secondary outcomes, and <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> reported results from the disease‐specific questionnaire, and one of the generic QoL questionnaires. </p> <p>All studies reported on postoperative pain, although they each used different types of measurement scales and different time points; they each recorded time to return to work, procedure duration and postprocedural complications at six weeks. Two studies supplied information about postoperative analgesia (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>), length of stay in hospital (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>), participants' satisfaction with cosmetic appearance (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>), and Venous Clinical Severity Score (VCSS) (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>). </p> <p>In <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> and <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>, there was a higher percentage of women (191/281, i.e. 68%) and the mean age of participants ranged from 47 years to 52 years. The length of follow‐up ranged from six weeks after the intervention to two years (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>). The <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> study has so far only published interim results for the first six weeks of follow‐up; in the trial register, the length of follow‐up is recorded as one year. </p> </section> <section id="CD010878-sec-0051"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD010878-sec-0135" title="">Characteristics of excluded studies</a> table for the full list of excluded studies and the reasons for exclusion. </p> <p>In total, we excluded 25 studies from this review (<a href="./references#CD010878-bbs2-0004" title="AriyoshiH , KambayashiJ‐I , TominagaS , HatanakaT . The possible risk of lower‐limb sclerotherapy causing an extended hypercoagulable state. Surgery Today1996;26(5):323‐7. ">Ariyoshi 1996</a>; <a href="./references#CD010878-bbs2-0005" title="BealeR , TheivacumarN , MavorAID , GoughMJ . Endovenous laser treatment (EVLT) or surgery of varicose veins? A randomised controlled trial in patients with saphenofemoral and long saphenous incompetence. Yearbook 2005, The Vascular Society of Great Britain &amp; Ireland. 2005:Abstract 77. ">Beale 2005</a>; <a href="./references#CD010878-bbs2-0006" title="CamposW , TorresIO , DaSilvaES , CasellaIB , Puech‐LeaoP . A prospective randomized study comparing polidocanol foam sclerotherapy with surgical treatment of patients with primary chronic venous insufficiency and ulcer. Annals of Vascular Surgery2015;29(6):1128‐35. ">Campos 2015</a>; <a href="./references#CD010878-bbs2-0007" title="BeresfordSAA , ChantADB , JonesHO , PiachaudD , WeddellJM . Varicose veins: a comparison of surgery and injection/compression sclerotherapy. Lancet1978;1(8070):921‐4. ChantADB , JonesHO , WeddellJM . Varicose veins: a comparison of surgery and injection/compression sclerotherapy. Lancet1972;2:1188‐91. PiachaudD , WeddellJM . The economics of treating varicose veins. International Journal of Epidemiology1972;1(3):287‐94. ">Chant 1972</a>; <a href="./references#CD010878-bbs2-0008" title="CompagnaR , DeVitoD , RossiR , FappianoF , DeMagistrisL , SodanoL , et al. A prospective randomised controlled trial comparing foam sclerotherapy combined with sapheno‐femoral ligation to surgical treatment of varicose veins. European Surgical Research2010;45(3‐4):267. ">Compagna 2010</a>; <a href="./references#CD010878-bbs2-0009" title="DoranFSA , WhiteM . A clinical trial designed to discover if the primary treatment of varicose veins should be by Fegan's method or by an operation. British Journal of Surgery1975;62:72‐6. ">Doran 1975</a>; <a href="./references#CD010878-bbs2-0010" title="EinarssonE , EklofB , NeglénP . Sclerotherapy or surgery as treatment for varicose veins: a prospective randomized study. Phlebology1993;8:22‐6. NeglénP , EinarssonE , EklofB . The functional long‐term value of different types of treatment for saphenous vein incompetence. Journal of Cardiovascular Surgery1993;34:295‐301. ">Einarsson 1993</a>; <a href="./references#CD010878-bbs2-0011" title="FigueiredoM , AraujoS , BarrosNJr , MirandaFJr . Results of surgical treatment compared with ultrasound‐guided foam sclerotherapy in patients with varicose veins: a prospective randomised study. European Journal of Vascular and Endovascular Surgery2009;38(6):758‐63. ">Figueiredo 2009</a>; <a href="./references#CD010878-bbs2-0012" title="FlessenkamperI , StengerD , HartmannM , RollS . Saphenofemorale neoreflux after endovenous laser therapy, high ligation/stripping or high ligation/laser therapy. Interim results of a prospective randomized controlled multicentre trial [Saphenofemoraler neoreflux nach lasertherapie, crossektomie/stripping oder crossektomie/ lasertherapie. Interimsergebnisse einer prospektiven randomisierten Multizenterstudie]. Phlebologie2012;41(6):289‐94. ">Flessenkamper 2012</a>; <a href="./references#CD010878-bbs2-0013" title="CarradiceD , MekakoA , HatfieldJ , ChetterI . Recurrent varicose veins are more common following surgery than EVLT ‐ results of a randomised controlled trial. The Vascular Society of Great Britain &amp; Ireland Yearbook 2009. 2009:86. CarradiceD , MekakoAI , HatfieldJ , ChetterIC . A randomised trial of EVLT vs surgery for varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 2008. 2008:91. CarradiceD , WallaceT , GohilR , ChetterI . A comparison of the effectiveness of treating those with and without the complications of superficial venous insufficiency. Annals of Surgery2014;260(2):396‐401. CarradiceD , WallaceT , SamuelN , GohilR , ChetterI . A comparison of the effectiveness of treating those with and without the complications of superficial venous insufficiency. Vascular Society of Great Britain and Ireland Annual General Meeting. 2012:38. ">HELP 1</a>; <a href="./references#CD010878-bbs2-0014" title="HobbsJT . Surgery and sclerotherapy in the treatment of varicose veins. A random trial. Archives of Surgery1974;109:793‐6. HobbsJT . Surgery or sclerotherapy for varicose veins. 10 year results of a random trial. In: TesiM , DormandyJA editor(s). Superficial and Deep Venous Diseases of the Lower Limbs / Surgical Therapy. Turin: Panminerva Medica, 1984:243‐8. HobbsJT . The treatment of varicose veins. A random trial of injection‐compression therapy versus surgery. British Journal of Surgery1968;55(10):777‐80. ">Hobbs 1974</a>; <a href="./references#CD010878-bbs2-0015" title="ISRCTN06552809 . VNUS vs ClariVein for varicose veins. www.isrctn.com/ISRCTN06552809 Date first received: 22 July 2012. ">ISRCTN06552809</a>; <a href="./references#CD010878-bbs2-0016" title="ISRCTN08060326 . Endovenous laser ablation (EVLA), radio frequency (RF), foam sclerotherapy and stripping for treatment of varicose veins. www.isrctn.com/ISRCTN08060326 Date first received: 31 July 2009. ">ISRCTN08060326</a>; <a href="./references#CD010878-bbs2-0017" title="IwamotoS , IkedaM , KawasakiT , MondenM . Treatment of varicose veins: an assessment of intraoperative and postoperative compression sclerotherapy. Annals of Vascular Surgery2003;17(3):290‐5. ">Iwamoto 2003</a>; <a href="./references#CD010878-bbs2-0018" title="JakobsenBH . The value of different forms of treatment for varicose veins. British Journal of Surgery1979;66:182‐4. ">Jakobsen 1979</a>; <a href="./references#CD010878-bbs2-0019" title="KalodikiE , LattimerCR , AzzamM , ShawishE , BountouroglouD , GeroulakosG . Long‐term results of a randomized controlled trial on ultrasound‐guided foam sclerotherapy combined with saphenofemoral ligation vs standard surgery for varicose veins. Journal of Vascular Surgery2012;55(2):451‐7. ">Kalodiki 2012</a>; <a href="./references#CD010878-bbs2-0020" title="LiuP , RenS , YangY , LiuJ , YeZ , LinF . Intravenous catheter‐guided laser ablation: a novel alternative for branch varicose veins. International Surgery2011;96(4):331‐6. ">Liu 2011</a>; <a href="./references#CD010878-bbs2-0021" title="BoersmaD , vanEekerenRR , KelderHJ , WersonDA , HolewijnS , SchreveMA , et al. Mechanochemical endovenous ablation versus radiofrequency ablation in the treatment of primary small saphenous vein insufficiency (MESSI trial): study protocol for a randomized controlled trial. Trials2014;15:421. [DOI: 10.1186/1745‐6215‐15‐421] ">MESSI trial 2014</a>; <a href="./references#CD010878-bbs2-0022" title="OgawaT , HoshinoS , MakimuraS , ShigematsuH , AzumaN , SasajimaT , et al. Endovenous laser ablation compared with stripping ‐ multicenter RCT in Japan. American Venous Forum Annual Meeting; 2008 Feb; Charleston, SC, USA. 2008. ">Ogawa 2008</a>; <a href="./references#CD010878-bbs2-0023" title="MichaelsJA , CampbellWB , BrazierJE , MacIntyreJB , PalfreymanSJ , RatcliffeJ , et al. Randomised clinical trial, observational study and assessment of cost‐effectiveness of the treatment of varicose veins (REACTIV trial). Health Technology Assessment (Winchester, England)2006;10(13):1‐196. ">REACTIV trial 2006</a>; <a href="./references#CD010878-bbs2-0024" title="SeddonJ . The management of varicose veins. British Journal of Surgery1973;60(5):345‐7. ">Seddon 1973</a>; <a href="./references#CD010878-bbs2-0025" title="ShoulerPJ , RunchmanPC . Varicose veins: optimum compression after surgery and sclerotherapy. Annal of the Royal College of Surgeons of England1989;71:402‐4. ">Shouler 1989</a>; <a href="./references#CD010878-bbs2-0026" title="BelcaroG , CesaroneMR , DiRenzoA , BrandoliniR , CoenL , AcerbiG , et al. Foam‐sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10‐year, prospective, randomized, controlled, trial (VEDICO trial). Angiology2003;54(3):307‐15. BelcaroG , ChristopoulosD , VasdekisS . Treatment of superficial venous incompetence with the SAVAS technique. (Section ambulatoire des varices avec sclerotherapie). A four year randomised, controlled trial comparing venous hemodynamic and costing after SAVAS, sclerotherapy and the dentist's technique. Journal des Maladies Vasculaires1991;16:23‐7. BelcaroG , DugallM , VasdekisS , ChristopoulosD , LauroraG , NicolaidesAN , et al. Comparison between endovascular sclerotherapy, surgery and surgery plus sclerotherapy in the treatment of superficial vein insufficiency. A randomized study on 10 years follow‐up. Angeiologie1998;50(1):57‐61. BelcaroG , NicolaidesAN , RicciA , DugallM , ErrichiBM , VasdekisS , et al. Endovascular sclerotherapy, surgery, and surgery plus sclerotherapy in superficial venous incompetence: a randomized, 10‐year follow‐up trial ‐ final results. Angiology2000;51(7):529‐34. ">VEDICO trial 1998</a>; <a href="./references#CD010878-bbs2-0027" title="WilhelmiM , HochA , HochW , PichlmaierAM , TeebkenOE , BisdasT , et al. Effectiveness and clinical outcome following endovenous therapy of primary varicose veins: first results of a randomised, prospective study comparing the VNUS closure fast system, 980nm and 1470nm lasers and conventional surgery. XVI World Congress of the Union Internationale de Phlebologie Abstract Book. 2009. ">Wilhelmi 2009</a>; <a href="./references#CD010878-bbs2-0028" title="WrightD . European randomized controlled trial of Varisolve® PD microfoam compared with alternative therapy in management of moderate‐to‐severe varicose veins: preliminary results. UIP World Congress Chapter Meeting; 2003 Aug 27‐31; San Diego, CA. 2003. WrightD , GobinJP , BradburyAW , Coleridge‐SmithP , SpoelstraH , BerridgeD , et al. Varisolve polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology2006;21(4):180‐90. ">Wright 2006</a>). Some studies were excluded for multiple reasons. We summarise here the main reasons for exclusion. In four studies, the participant population being studied was different to the one specified in the protocol for this review (<a href="./references#CD010878-bbs2-0005" title="BealeR , TheivacumarN , MavorAID , GoughMJ . Endovenous laser treatment (EVLT) or surgery of varicose veins? A randomised controlled trial in patients with saphenofemoral and long saphenous incompetence. Yearbook 2005, The Vascular Society of Great Britain &amp; Ireland. 2005:Abstract 77. ">Beale 2005</a>; <a href="./references#CD010878-bbs2-0008" title="CompagnaR , DeVitoD , RossiR , FappianoF , DeMagistrisL , SodanoL , et al. A prospective randomised controlled trial comparing foam sclerotherapy combined with sapheno‐femoral ligation to surgical treatment of varicose veins. European Surgical Research2010;45(3‐4):267. ">Compagna 2010</a>; <a href="./references#CD010878-bbs2-0013" title="CarradiceD , MekakoA , HatfieldJ , ChetterI . Recurrent varicose veins are more common following surgery than EVLT ‐ results of a randomised controlled trial. The Vascular Society of Great Britain &amp; Ireland Yearbook 2009. 2009:86. CarradiceD , MekakoAI , HatfieldJ , ChetterIC . A randomised trial of EVLT vs surgery for varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 2008. 2008:91. CarradiceD , WallaceT , GohilR , ChetterI . A comparison of the effectiveness of treating those with and without the complications of superficial venous insufficiency. Annals of Surgery2014;260(2):396‐401. CarradiceD , WallaceT , SamuelN , GohilR , ChetterI . A comparison of the effectiveness of treating those with and without the complications of superficial venous insufficiency. Vascular Society of Great Britain and Ireland Annual General Meeting. 2012:38. ">HELP 1</a>; <a href="./references#CD010878-bbs2-0016" title="ISRCTN08060326 . Endovenous laser ablation (EVLA), radio frequency (RF), foam sclerotherapy and stripping for treatment of varicose veins. www.isrctn.com/ISRCTN08060326 Date first received: 31 July 2009. ">ISRCTN08060326</a>); in four studies, there was no mention of participants with SSV varices (<a href="./references#CD010878-bbs2-0006" title="CamposW , TorresIO , DaSilvaES , CasellaIB , Puech‐LeaoP . A prospective randomized study comparing polidocanol foam sclerotherapy with surgical treatment of patients with primary chronic venous insufficiency and ulcer. Annals of Vascular Surgery2015;29(6):1128‐35. ">Campos 2015</a>; <a href="./references#CD010878-bbs2-0012" title="FlessenkamperI , StengerD , HartmannM , RollS . Saphenofemorale neoreflux after endovenous laser therapy, high ligation/stripping or high ligation/laser therapy. Interim results of a prospective randomized controlled multicentre trial [Saphenofemoraler neoreflux nach lasertherapie, crossektomie/stripping oder crossektomie/ lasertherapie. Interimsergebnisse einer prospektiven randomisierten Multizenterstudie]. Phlebologie2012;41(6):289‐94. ">Flessenkamper 2012</a>; <a href="./references#CD010878-bbs2-0024" title="SeddonJ . The management of varicose veins. British Journal of Surgery1973;60(5):345‐7. ">Seddon 1973</a>; <a href="./references#CD010878-bbs2-0027" title="WilhelmiM , HochA , HochW , PichlmaierAM , TeebkenOE , BisdasT , et al. Effectiveness and clinical outcome following endovenous therapy of primary varicose veins: first results of a randomised, prospective study comparing the VNUS closure fast system, 980nm and 1470nm lasers and conventional surgery. XVI World Congress of the Union Internationale de Phlebologie Abstract Book. 2009. ">Wilhelmi 2009</a>); and in another two, the study did not distinguish between participants with GSV varices and SSV varices (<a href="./references#CD010878-bbs2-0011" title="FigueiredoM , AraujoS , BarrosNJr , MirandaFJr . Results of surgical treatment compared with ultrasound‐guided foam sclerotherapy in patients with varicose veins: a prospective randomised study. European Journal of Vascular and Endovascular Surgery2009;38(6):758‐63. ">Figueiredo 2009</a>; <a href="./references#CD010878-bbs2-0022" title="OgawaT , HoshinoS , MakimuraS , ShigematsuH , AzumaN , SasajimaT , et al. Endovenous laser ablation compared with stripping ‐ multicenter RCT in Japan. American Venous Forum Annual Meeting; 2008 Feb; Charleston, SC, USA. 2008. ">Ogawa 2008</a>). The study design in one study differed to the design specified in the protocol for this review (<a href="./references#CD010878-bbs2-0028" title="WrightD . European randomized controlled trial of Varisolve® PD microfoam compared with alternative therapy in management of moderate‐to‐severe varicose veins: preliminary results. UIP World Congress Chapter Meeting; 2003 Aug 27‐31; San Diego, CA. 2003. WrightD , GobinJP , BradburyAW , Coleridge‐SmithP , SpoelstraH , BerridgeD , et al. Varisolve polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology2006;21(4):180‐90. ">Wright 2006</a>); in four studies the intervention was not one of the three specified for this review (<a href="./references#CD010878-bbs2-0004" title="AriyoshiH , KambayashiJ‐I , TominagaS , HatanakaT . The possible risk of lower‐limb sclerotherapy causing an extended hypercoagulable state. Surgery Today1996;26(5):323‐7. ">Ariyoshi 1996</a>; <a href="./references#CD010878-bbs2-0017" title="IwamotoS , IkedaM , KawasakiT , MondenM . Treatment of varicose veins: an assessment of intraoperative and postoperative compression sclerotherapy. Annals of Vascular Surgery2003;17(3):290‐5. ">Iwamoto 2003</a>; <a href="./references#CD010878-bbs2-0019" title="KalodikiE , LattimerCR , AzzamM , ShawishE , BountouroglouD , GeroulakosG . Long‐term results of a randomized controlled trial on ultrasound‐guided foam sclerotherapy combined with saphenofemoral ligation vs standard surgery for varicose veins. Journal of Vascular Surgery2012;55(2):451‐7. ">Kalodiki 2012</a>; <a href="./references#CD010878-bbs2-0020" title="LiuP , RenS , YangY , LiuJ , YeZ , LinF . Intravenous catheter‐guided laser ablation: a novel alternative for branch varicose veins. International Surgery2011;96(4):331‐6. ">Liu 2011</a>); in three studies, the comparator was not conventional surgery (<a href="./references#CD010878-bbs2-0015" title="ISRCTN06552809 . VNUS vs ClariVein for varicose veins. www.isrctn.com/ISRCTN06552809 Date first received: 22 July 2012. ">ISRCTN06552809</a>; <a href="./references#CD010878-bbs2-0021" title="BoersmaD , vanEekerenRR , KelderHJ , WersonDA , HolewijnS , SchreveMA , et al. Mechanochemical endovenous ablation versus radiofrequency ablation in the treatment of primary small saphenous vein insufficiency (MESSI trial): study protocol for a randomized controlled trial. Trials2014;15:421. [DOI: 10.1186/1745‐6215‐15‐421] ">MESSI trial 2014</a>; <a href="./references#CD010878-bbs2-0026" title="BelcaroG , CesaroneMR , DiRenzoA , BrandoliniR , CoenL , AcerbiG , et al. Foam‐sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10‐year, prospective, randomized, controlled, trial (VEDICO trial). Angiology2003;54(3):307‐15. BelcaroG , ChristopoulosD , VasdekisS . Treatment of superficial venous incompetence with the SAVAS technique. (Section ambulatoire des varices avec sclerotherapie). A four year randomised, controlled trial comparing venous hemodynamic and costing after SAVAS, sclerotherapy and the dentist's technique. Journal des Maladies Vasculaires1991;16:23‐7. BelcaroG , DugallM , VasdekisS , ChristopoulosD , LauroraG , NicolaidesAN , et al. Comparison between endovascular sclerotherapy, surgery and surgery plus sclerotherapy in the treatment of superficial vein insufficiency. A randomized study on 10 years follow‐up. Angeiologie1998;50(1):57‐61. BelcaroG , NicolaidesAN , RicciA , DugallM , ErrichiBM , VasdekisS , et al. Endovascular sclerotherapy, surgery, and surgery plus sclerotherapy in superficial venous incompetence: a randomized, 10‐year follow‐up trial ‐ final results. Angiology2000;51(7):529‐34. ">VEDICO trial 1998</a>); and in seven studies, the method of sclerotherapy used was not UGFS (<a href="./references#CD010878-bbs2-0007" title="BeresfordSAA , ChantADB , JonesHO , PiachaudD , WeddellJM . Varicose veins: a comparison of surgery and injection/compression sclerotherapy. Lancet1978;1(8070):921‐4. ChantADB , JonesHO , WeddellJM . Varicose veins: a comparison of surgery and injection/compression sclerotherapy. Lancet1972;2:1188‐91. PiachaudD , WeddellJM . The economics of treating varicose veins. International Journal of Epidemiology1972;1(3):287‐94. ">Chant 1972</a>; <a href="./references#CD010878-bbs2-0009" title="DoranFSA , WhiteM . A clinical trial designed to discover if the primary treatment of varicose veins should be by Fegan's method or by an operation. British Journal of Surgery1975;62:72‐6. ">Doran 1975</a>; <a href="./references#CD010878-bbs2-0010" title="EinarssonE , EklofB , NeglénP . Sclerotherapy or surgery as treatment for varicose veins: a prospective randomized study. Phlebology1993;8:22‐6. NeglénP , EinarssonE , EklofB . The functional long‐term value of different types of treatment for saphenous vein incompetence. Journal of Cardiovascular Surgery1993;34:295‐301. ">Einarsson 1993</a>; <a href="./references#CD010878-bbs2-0014" title="HobbsJT . Surgery and sclerotherapy in the treatment of varicose veins. A random trial. Archives of Surgery1974;109:793‐6. HobbsJT . Surgery or sclerotherapy for varicose veins. 10 year results of a random trial. In: TesiM , DormandyJA editor(s). Superficial and Deep Venous Diseases of the Lower Limbs / Surgical Therapy. Turin: Panminerva Medica, 1984:243‐8. HobbsJT . The treatment of varicose veins. A random trial of injection‐compression therapy versus surgery. British Journal of Surgery1968;55(10):777‐80. ">Hobbs 1974</a>; <a href="./references#CD010878-bbs2-0018" title="JakobsenBH . The value of different forms of treatment for varicose veins. British Journal of Surgery1979;66:182‐4. ">Jakobsen 1979</a>; <a href="./references#CD010878-bbs2-0023" title="MichaelsJA , CampbellWB , BrazierJE , MacIntyreJB , PalfreymanSJ , RatcliffeJ , et al. Randomised clinical trial, observational study and assessment of cost‐effectiveness of the treatment of varicose veins (REACTIV trial). Health Technology Assessment (Winchester, England)2006;10(13):1‐196. ">REACTIV trial 2006</a>; <a href="./references#CD010878-bbs2-0025" title="ShoulerPJ , RunchmanPC . Varicose veins: optimum compression after surgery and sclerotherapy. Annal of the Royal College of Surgeons of England1989;71:402‐4. ">Shouler 1989</a>). </p> </section> </section> <section id="CD010878-sec-0052"> <h3 class="title">Risk of bias in included studies</h3> <p>Detailed risk of bias assessments for each of the three studies are reported in the 'Risk of bias' section of the <a href="./references#CD010878-sec-0134" title="">Characteristics of included studies</a> table; in addition, see <a href="#CD010878-fig-0002">Figure 2</a> and <a href="#CD010878-fig-0003">Figure 3</a> for summaries of the methodological quality of these studies. </p> <div class="figure" id="CD010878-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010878-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010878-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010878-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010878-sec-0053"> <h4 class="title">Allocation</h4> <p>The review authors judged the risk of selection bias for the three included studies as low, as each study reported adequate methods for random sequence generation and allocation concealment (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>). </p> </section> <section id="CD010878-sec-0054"> <h4 class="title">Blinding</h4> <p>Blinding of participants and personnel was not possible in these three studies; consequently, the review authors judged the risk of performance bias as high. </p> <p>It was not possible to blind postoperative assessors to the procedure that the participants had undergone. However, two studies were at low risk of detection bias since the trial authors were aware of the risk and had attempted to address it by using "independent accredited vascular technologists rather than by the surgeons who had performed the treatment" (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>) and objective validated instruments to record clinical outcomes, and both disease‐specific and generic QoL instruments that had all been validated to measure efficacy of venous treatment (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>). The third study did not address the issue of blinding of outcome assessors, and the review authors judged it at high risk of detection bias (<a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>). </p> </section> <section id="CD010878-sec-0055"> <h4 class="title">Incomplete outcome data</h4> <p>In two studies, the number of participants was clearly stated for each outcome reported, and the review authors judged the risk of attrition bias as low (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>). In the third study, the review authors judged the risk of attrition bias as unclear, as 7% of the participants were unaccounted for in the analysis of the success rate of the procedure, and other outcomes were reported as means, with no indication of the number of participants contributing to the outcome (<a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>). </p> </section> <section id="CD010878-sec-0056"> <h4 class="title">Selective reporting</h4> <p>There was no evidence of reporting bias in the three studies. The protocol was available for one study (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>), and all prespecified outcomes were reported; for the other two studies, all outcomes specified in the trial register were reported (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>), although the <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> report was an interim report and the report for one‐year results is still awaited. </p> </section> <section id="CD010878-sec-0057"> <h4 class="title">Other potential sources of bias</h4> <p>One study was at low risk of any other bias, since its authors explicitly reported that its sample‐size calculation was based on the primary outcome, and that it was underpowered for a "detailed QoL analysis (secondary outcomes) and therefore cannot confirm or refute any true benefit of EVLA over surgery in this area" (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>). Another study was at unclear risk of other forms of bias, since its 2:1 (EVLA:surgery) allocation of participants was not explicitly reported in either the trial register or the methods section (<a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>). The third study was potentially underpowered and at high risk of bias because it recruited participants with either GSV or SSV varices (or both), and recruited very few participants with SSV varices (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>). </p> </section> </section> <section id="CD010878-sec-0058"> <h3 class="title" id="CD010878-sec-0058">Effects of interventions</h3> <p>See: <a href="./full#CD010878-tbl-0001"><b>Summary of findings for the main comparison</b> Endovenous laser ablation compared to conventional surgery for short saphenous vein varices</a>; <a href="./full#CD010878-tbl-0002"><b>Summary of findings 2</b> Ultrasound‐guided foam sclerotherapy compared to conventional surgery for short saphenous vein varices</a> </p> <p>Nearly all the outcome measures prespecified in our protocol, and the <a href="#CD010878-sec-0021">Methods</a> section, were presented in the original trial report for <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS;</a> however, the CLASS authors did not stratify their results according to GSV/SSV for most outcomes. We contacted the study authors with a request for data pertaining to participants with SSV varices and, although the study authors responded positively to our request for stratified data, it had not been received by the time of completion of this review. As a consequence, we are unable to provide data for <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>, in either treatment comparison, for the following outcomes: </p> <p> <ul id="CD010878-list-0012"> <li> <p>clinical evidence of recurrence at one year;</p> </li> <li> <p>QoL AVVQ scores;</p> </li> <li> <p>QoL EQ‐5D scores;</p> </li> <li> <p>QoL 36‐item Short Form (SF‐36) scores;</p> </li> <li> <p>postoperative pain;</p> </li> <li> <p>postoperative complications;</p> </li> <li> <p>duration of hospital stay;</p> </li> <li> <p>return to work;</p> </li> <li> <p>duration of procedure.</p> </li> </ul> </p> <p>In the <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> trial, data were only available for the first six weeks of follow‐up; we contacted the study authors who responded positively to our request for data up to one year after intervention (according to the study protocol), but data were not received by the time of completion of this review. As a consequence, we are unable to provide data for <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>, in the EVLA versus surgery comparison, for: </p> <p> <ul id="CD010878-list-0013"> <li> <p>recurrence of reflux at one year;</p> </li> <li> <p>all QoL scores at one year.</p> </li> </ul> </p> <section id="CD010878-sec-0059"> <h4 class="title">Primary outcomes</h4> <section id="CD010878-sec-0060"> <h5 class="title">Recanalisation or persistence of reflux at six weeks</h5> <p>Ultrasound was used to determine recanalisation. The three studies used different thresholds for definition of reflux: reflux was defined as: a retrograde flow of 1 second or more on spectral Doppler after augmentation (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>); greater than 0.5 seconds for incompetence of the superficial venous system (and greater than 0.8 seconds for deep veins) (<a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>); and greater than 1 second (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>). </p> <section id="CD010878-sec-0061"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>All three studies evaluated recanalisation or persistence of reflux (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>). At six weeks, there were significantly fewer instances in the EVLA (3/173 participants) group compared to surgery (29/116 participants). In the fixed‐effect meta‐analysis, there was a statistically significant difference between the two groups: the OR for recanalisation or persistence of reflux at six weeks was 0.07 in favour of EVLA (95% CI 0.02 to 0.22; P &lt; 0.00001, I<sup>2</sup> = 51%, moderate‐quality evidence) (<a href="./references#CD010878-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD010878-sec-0062"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>Only one study compared UGFS with conventional surgery (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>)<i>.</i> Of the 21 participants randomised to each group and who underwent the procedure, data at six weeks were available for 16 participants in the UGFS group and 17 in the surgery group. In the UGFS group, there were two incidences of recanalisation or persistence of reflux at six weeks compared to five participants in the surgical group; the OR of recanalisation or persistence of reflux at six weeks when UGFS was compared with surgery was 0.34 (95% CI 0.06 to 2.10; P = 0.25, low‐quality evidence), showing no statistically significant difference between the two treatment groups (<a href="./references#CD010878-fig-0011" title="">Analysis 2.1</a>). </p> </section> </section> <section id="CD010878-sec-0063"> <h5 class="title">Recurrence of reflux at one year</h5> <section id="CD010878-sec-0064"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>Recurrence of reflux at one year was determined by recanalisation on ultrasound. One‐year follow‐up data were available from <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> only; <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> reported six‐month follow‐up data and data from <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> could not be obtained (<a href="./references#CD010878-fig-0005" title="">Analysis 1.2</a>). In the <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> trial, at six months, reflux was observed in 1/9 participants in the EVLA group, and 5/11 participants in the surgery group (OR 0.15, 95% CI 0.01 to 1.64). In <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>, reflux was observed in 3/48 participants in the EVLA group and 10/51 participants in the surgery group (OR 0.27, 95% CI 0.07 to 1.06). Pooled data suggested a significantly higher number of recurrences in the surgery group compared to the EVLA group (OR 0.24, 95% CI 0.07 to 0.77; P = 0.02, I<sup>2</sup> = 0%, low‐quality evidence). </p> <p><a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> also published two‐year follow‐up data, which provided no evidence of a difference between the number of recurrences in surgery (15/44 participants) and EVLA (8/44 participants) (OR 0.43, 95% CI 0.16 to 1.15; P = 0.09) (<a href="./references#CD010878-fig-0006" title="">Analysis 1.3</a>). </p> </section> <section id="CD010878-sec-0065"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>In the <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study, at the clinic six months after the procedure, there was no significant difference in the incidence of reflux between UGFS (8/17 participants) and surgery (6/14 participants) groups (OR 1.19, 95% CI 0.29 to 4.92, low‐quality evidence) (<a href="./references#CD010878-fig-0012" title="">Analysis 2.2</a>). </p> </section> </section> <section id="CD010878-sec-0066"> <h5 class="title">Clinical evidence of recurrence at one year</h5> <p>The most common clinical evidence of recurrence was the presence of new visible varicose veins. </p> <section id="CD010878-sec-0067"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>In <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>, there was clinical evidence of recurrence one year after the procedure in 5/48 participants in the EVLA group, and 9/51 in the surgical group. The OR for clinical evidence of recurrence one year after the procedure when EVLA was compared with surgery was 0.54 (95% CI 0.17 to 1.75, low‐quality evidence), demonstrating no difference between the two treatment groups (<a href="./references#CD010878-fig-0007" title="">Analysis 1.4</a>). <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> did not report this outcome. In the <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study, results for this outcome were not presented separately for people with SSV varices; therefore, results for this outcome are not available from that study. </p> </section> <section id="CD010878-sec-0068"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>In the <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study, results for this outcome were not presented separately for people with SSV varices; therefore, results are not available for this outcome. </p> </section> </section> <section id="CD010878-sec-0069"> <h5 class="title">Reintervention (due to technical failure)</h5> <section id="CD010878-sec-0070"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>Neither <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> nor <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> reported reintervention (due to technical failure). </p> <p>In <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>, four participants randomised to EVLA required further treatment: one participant underwent a second EVLA, and three participants underwent UGFS; in the surgical group, three participants underwent EVLA and one participant had ultrasound‐guided perforator ligation. </p> </section> <section id="CD010878-sec-0071"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p><a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> did not report results for this outcome separately for people with SSV varices; therefore, results are not available for this outcome. </p> </section> </section> </section> <section id="CD010878-sec-0072"> <h4 class="title">Secondary outcomes</h4> <section id="CD010878-sec-0073"> <h5 class="title">Quality of life</h5> <p>All included studies measured QoL with at least two different participant‐reported questionnaires ‐ the disease‐specific AVVQ and the generic EuroQoL Group 5‐Dimension Self‐Report Questionnaire (EQ‐5D) (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>). In addition, two studies used a second participant‐reported generic questionnaire ‐ the Medical Outcomes SF‐36 (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>). </p> </section> <section id="CD010878-sec-0074"> <h5 class="title">Quality of life ‐ Aberdeen Varicose Veins Questionnaire</h5> <p>AVVQ scores range from 0 (no impact on QoL) to 100 (greatest possible impact on QoL).</p> <section id="CD010878-sec-0075"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>See <a href="#CD010878-tbl-0003">Table 1</a> for a breakdown of results over time by study. In the <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> study, both groups reported a slight increase in the AVVQ score one week after the procedure (i.e. a slight deterioration), but thereafter there was a steady decrease in scores for both treatment groups during the first year after the procedure, indicating a steady and continuing improvement (P &lt; 0.001). There was no statistically significant difference between the AVVQ scores of the two treatment groups at each time point. </p> <div class="table" id="CD010878-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Disease‐specific quality of life scores (AVVQ) over follow‐up: EVLA versus surgery</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Time point</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. "><b>HELP 2</b> </a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. "><b>VESPA</b> </a> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>AVVQ scores (mean (SD))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>P value<sup>§</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>AVVQ scores (mean (SD))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>P value<sup>§§</sup> </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>EVLA</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgery</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>EVLA</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgery</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.2 (6.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.5 (6.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.215</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.0 (10.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.9 (5.9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.2 (6.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.9 (6.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.092</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.8 (7.7)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.4 (8.9)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8 (7.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8 (5.5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.996</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.0 (7.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.7 (8.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1 (4.9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.2 (5.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.787</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2 (6.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3 (5.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.327</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*These scores were measured at 2 weeks after the procedure'<br/> <sup>§</sup>Student <i>t</i>‐test for intergroup analysis'<br/> <sup>§§</sup>Individual P values were not reported, but the authors reported there were no significant differences between the groups (P &lt; 0.001). </p> <p>AVVQ: Aberdeen Varicose Veins Questionnaire; EVLA: endovenous laser ablation; nr: not recorded. </p> </div> </div> <p>In the <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> study, there were no statistically significant differences in AVVQ scores between the two groups, and in both groups the scores decreased significantly between the two‐ and six‐week appointments, indicating an improvement in disease‐specific QoL (P &lt; 0.001). </p> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report results for QoL measured by AVVQ separately for people with SSV varices; therefore, results were not available. </p> <p>When we pooled the six‐week AVVQ scores for <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> and <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>, there was no evidence of a difference in AVVQ score between the two procedures; the MD in AVVQ scores between the interventions was 0.15 (95% CI ‐1.65 to 1.95; I<sup>2</sup> = 0%, P = 0.87; moderate‐quality evidence) (<a href="./references#CD010878-fig-0008" title="">Analysis 1.5</a>). The only study that reported AVVQ scores at one year was <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; however, there was insufficient evidence of a difference between EVLA and surgery (MD in AVVQ scores ‐1.08 (95% CI ‐3.39 to 1.23, low‐quality evidence) (<a href="./references#CD010878-fig-0009" title="">Analysis 1.6</a>)). </p> </section> <section id="CD010878-sec-0076"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report results for QoL measured by AVVQ separately for people with SSV varices; therefore, results were not available. </p> </section> </section> <section id="CD010878-sec-0077"> <h5 class="title">Quality of life ‐ EuroQoL Group 5‐Dimension Questionnaire</h5> <p>EQ‐5D is a standardised measure of health status developed by the EuroQoL Group to provide a simple, generic measure of health for clinical and economic appraisal. The EQ‐5D has five dimensions (mobility, self‐care, usual activities, pain/discomfort and anxiety/depression), and each dimension has 3 levels (no problems, some problems and extreme problems); level 1 represents the best score. </p> <section id="CD010878-sec-0078"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>See <a href="#CD010878-tbl-0004">Table 2</a> for a breakdown of results over time by study. We noted that the EQ‐5D values were very different between the <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> trial and the other two studies (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>), and query therefore whether the conversion of the EQ‐5D questionnaire to the EQ‐5D Index was calculated in the same way for the English and Dutch versions. For this reason, we decided not to pool the EQ‐5D results in a meta‐analysis. The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report results for QoL measured by EQ‐5D separately for people with SSV varices; therefore, results were not available. </p> <div class="table" id="CD010878-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Generic quality of life scores (EQ‐5D) over follow‐up: EVLA versus surgery</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Time point</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. "><b>HELP 2</b> </a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. "><b>VESPA</b> </a> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>EQ‐5D (median (IQR))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>P value</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>EQ‐5D (mean (SD))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>P value</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>EVLA</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgery</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>EVLA</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgery</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81 (0.73 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 (0.80 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.249</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.19)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.19 (0.19)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80 (0.70 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.77 (0.69 to 0.88)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.256</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.13)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.84 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.81 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.802</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.09 (0.16)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 (0.16)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 (0.76 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.85 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.095</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.93 (0.78 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.81 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.119</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>EQ‐5D EuroQoL 5‐Dimension; EVLA Endovenous laser ablation; nr: not recorded.</p> </div> </div> <p>In the <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> study, there was no significant difference between the index scores of each treatment group at each time point. At six weeks, both groups had a median score of 1 (best possible), which the surgery group maintained at 12 weeks and one year; the EVLA group median was 0.97 at 12 weeks and 0.93 at one year. </p> <p>The <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> study used the Dutch version of the EQ‐5D. The authors reported "No significant differences were seen between the two groups. Scores for both groups were significantly improved over time (P = 0.017)." </p> </section> <section id="CD010878-sec-0079"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report QoL measured by EQ‐5D separately for people with SSV varices; therefore, results were not available. </p> </section> </section> <section id="CD010878-sec-0080"> <h5 class="title">Quality of life ‐ 36‐Item Short‐Form Health Survey</h5> <p>The SF‐36 measures QoL across eight emotional and physical domains, with scores ranging from 0 (worst QoL) to 100 (best QoL); physical and mental summary scores may also be calculated. </p> <section id="CD010878-sec-0081"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>See <a href="#CD010878-tbl-0005">Table 3</a> for a breakdown of results over time by study. In the <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> study, across five of the eight SF‐36 domains, both groups achieved higher scores in the SF‐36 over time (i.e. better functioning). In the general health domain, although the score of the EVLA group reflected an improvement between weeks one and six, the score at the end of the year was slightly lower than that at six weeks. In the vitality and mental health domains, the deterioration for the EVLA group occurred after 12 weeks; however, the surgery group maintained an improvement in scores throughout the year. </p> <div class="table" id="CD010878-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Generic quality of life scores (SF‐36) over follow‐up: EVLA versus surgery</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>SF‐36 domain</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Time point</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. "><b>HELP 2</b> </a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EVLA (median (IQR))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgery (median (IQR))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>P value</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Physical functioning</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (70 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.891</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 (61 to 95)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (50 to 90)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.095</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (85 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.708</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (80 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (85 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.766</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (78 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (85 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.896</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Role physical</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (50 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (50 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.969</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 (0 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 (0 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.277</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (31 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (25 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.644</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (50 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.779</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.502</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Bodily pain</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 (51 to 84)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 (42 to 88)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.826</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62 (41 to 84)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 (41 to 74)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.325</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (62 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 (54 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.469</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (62 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (62 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.483</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (62 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (62 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.280</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>General health</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (53 to 84)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (52 to 87)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.606</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (56 to 82)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (53 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.341</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (57 to 89)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82 (67 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.175</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75 (62 to 87)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (65 to 91)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.403</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 (57 to 87)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82 (67 to 93)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.077</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Vitality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 (46 to 75)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65 (50 to 80)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.072</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (45 to 74)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 (45 to 74)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.690</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68 (45 to 80)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (60 to 85)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.325</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (45 to 80)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (50 to 80)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.774</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65 (50 to 75)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75 (54 to 85)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.136</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Social functioning</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.420</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88 (63 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75 (50 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.082</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (63 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.198</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.877</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (78 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.364</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Role emotional</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.820</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (67 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.498</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.582</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (67 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.155</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.510</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Mental health</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78 (60 to 87)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 (72 to 88)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.167</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78 (65 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (68 to 91)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.680</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 (68 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (76 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.369</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (72 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88 (74 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.456</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 (68 to 90)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88 (72 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.071</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>EVLA: endovenous laser ablation; SF‐36: 36‐Item Short Form Health Survey.</p> </div> </div> <p>The <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> study did not use the SF‐36 to measure QoL. The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report QoL measured by SF‐36 separately for people with SSV varices; therefore, results were not available. </p> </section> <section id="CD010878-sec-0082"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report QoL measured by SF‐36 separately for people with SSV varices; therefore, results were not available. </p> </section> </section> <section id="CD010878-sec-0083"> <h5 class="title">Postoperative pain ‐ Visual Analogue Scale scores</h5> <section id="CD010878-sec-0084"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p><a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> and <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> measured pain on a VAS from 0 (no pain) to 10 (worst pain imaginable), and <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> measured pain on a VAS from 0 (no pain) to 100 (worst pain imaginable). The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report results for postoperative pain measured using a VAS separately for people with SSV varices; therefore, results were not available. </p> <p>In <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>, participants kept a pain diary for the seven days immediately following the procedure. For the first day, participants in the EVLA group recorded a median pain score of 1.5 (interquartile range (IQR) 0.9 to 3.6), in contrast to participants in the surgery group who recorded a median pain score of 2.9 (IQR 0.9 to 5.8). During the week, the level of pain declined each day, but pain scores for the EVLA group were lower than those for the surgery group. The study authors reported that the difference in pain between the two groups was statistically significant for days four to seven (day four, P = 0.025; day five, P = 0.008; day six, P = 0.033; day seven, P = 0.042), although there was no difference in the frequency of analgesia intake. </p> <p><a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> recorded pain caused by varicose veins at baseline and at one, two and six weeks. One week after the procedure, mean scores were 31 (EVLA group) and 18 (surgery group); by week six, these scores were 6 (EVLA group) and 9 (surgery group). </p> </section> <section id="CD010878-sec-0085"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report results for postoperative pain measured using a VAS separately for people with SSV varices; therefore, results were not available. </p> </section> </section> <section id="CD010878-sec-0086"> <h5 class="title">Postoperative pain ‐ postoperative analgesia</h5> <section id="CD010878-sec-0087"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> trial did not report postoperative analgesia use. In <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>, there was no difference in the frequency of analgesia intake between participants in the EVLA and surgery groups, but there were no further details. <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> reported that participants "were prescribed analgesia (acetaminophen [paracetamol] and non‐steroidal anti‐inflammatory drugs)", but there were no further details of postprocedural analgesia. </p> </section> <section id="CD010878-sec-0088"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> trial did not report postoperative analgesia. </p> </section> </section> <section id="CD010878-sec-0089"> <h5 class="title">Postoperative pain ‐ participant complaints</h5> <section id="CD010878-sec-0090"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>None of the studies reported participant complaints of postoperative pain (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>). </p> </section> <section id="CD010878-sec-0091"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> trial did not report participant complaints of postoperative pain. </p> </section> </section> <section id="CD010878-sec-0092"> <h5 class="title">Postoperative complications</h5> <section id="CD010878-sec-0093"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>All three studies reported postoperative complications. The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report postoperative complications separately for people with SSV varices; therefore, results were not available. See <a href="#CD010878-tbl-0006">Table 4</a> for further details. DVT was recorded for 1/161 participants in the EVLA group and 1/104 participants in the surgery group. In both participants, the DVT had completely resolved after three to six months of oral anticoagulation, with ultrasound demonstrating a competent deep venous system with no clinical evidence of pulmonary embolism (265 participants, 2 studies, moderate‐quality evidence). </p> <div class="table" id="CD010878-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Postprocedural complications: EVLA versus surgery</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b> Complication</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b> Treatment group</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. "><b>HELP 2</b> </a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. "><b>VESPA</b> </a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> n</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> %</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> n</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> %</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>DVT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/110</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Thermal injury</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Sural nerve injury at 6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/51</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/110</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Sural nerve injury at 52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Wound infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Haematoma</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pigmentation/skin bruising</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/51</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Phlebitis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/51</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>DVT: deep venous thrombosis; EVLA: endovenous laser ablation; n: number of participants; nr: not reported. </p> </div> </div> <p>In <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>, 8% of participants in the EVLA group and 27% of participants in the surgery group reported sural nerve injury at six weeks, and <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> reported similar percentages; in both groups, most of these cases improved spontaneously. A small number of participants reported wound infection (surgery group, 2% in <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>, and 11% in <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>), and <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> reported haematoma, pigmentation or skin bruising and phlebitis. </p> <p>The only complications listed in the <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> trial were DVT; neurological complications such as numbness, hyperaesthesia and paraesthesia; and wound infection; it was not clear whether there were other complications, but they were not recorded, or whether these were the only complications encountered. </p> </section> <section id="CD010878-sec-0094"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report results for postoperative complications separately for people with SSV varices; therefore, results were not available. </p> </section> </section> <section id="CD010878-sec-0095"> <h5 class="title">Healing of ulcers</h5> <section id="CD010878-sec-0096"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>None of the studies reported healing of ulcers (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>). </p> </section> <section id="CD010878-sec-0097"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> trial did not report healing of ulcers. </p> </section> </section> <section id="CD010878-sec-0098"> <h5 class="title">Duration of hospital stay</h5> <section id="CD010878-sec-0099"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>Although the procedures in the <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> trial were intended to be performed as day‐case procedures, 1/53 participants in the EVLA group and 4/53 participants in the surgery group required an overnight stay after the intervention (the surgical participants were unsuitable for day‐case general anaesthesia). </p> <p>The <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> study did not report duration of hospital stay. The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report duration of hospital stay separately for people with SSV varices; therefore, results for this outcome were not available. </p> </section> <section id="CD010878-sec-0100"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report duration of hospital stay separately for people with SSV varices; therefore, results were not available. </p> </section> </section> <section id="CD010878-sec-0101"> <h5 class="title">Return to work</h5> <section id="CD010878-sec-0102"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>Although each study reported information regarding the length of time taken to return to work after interventional treatment, they used different methods to present this information, and, therefore, a meta‐analysis was not possible. </p> <p>In <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>, the median time from treatment date to return to work was seven days (IQR 3 to 14 days) for the EVLA group, and 21 days (IQR 13 to 24 days) for the surgery group; the study authors reported that participants allocated to EVLA returned to work more quickly than participants who had received surgery (P &lt; 0.001). </p> <p>The <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> trial, by contrast, asked participants at the two‐week clinic whether they had returned to work: 3/118 (2.4%) people in the EVLA group and 6/57 (11%) people in the surgery group had not returned to work within two weeks of the procedure as a result of the intervention they had received. The study authors reported that "these percentages were significantly different (P &lt; 0.05)." </p> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report results for return to work separately for people with SSV varices; therefore, results were not available. </p> </section> <section id="CD010878-sec-0103"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report results for return to work separately for people with SSV varices; therefore, results were not available. </p> </section> </section> <section id="CD010878-sec-0104"> <h5 class="title">Type of anaesthesia</h5> <section id="CD010878-sec-0105"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p><a href="#CD010878-tbl-0007">Table 5</a> shows the types of anaesthesia used in each trial for the different interventions. All studies used a local tumescent anaesthesia for EVLA; among the surgery groups, studies used general, regional or spinal anaesthesia (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>). </p> <div class="table" id="CD010878-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Type of anaesthesia</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type of anaesthesia</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local tumescent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>General or regional</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UGFS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local tumescent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>General</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local tumescent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>General or spinal</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>EVLA: endovenous laser ablation; UGFS: ultrasound‐guided foam sclerotherapy.</p> </div> </div> </section> <section id="CD010878-sec-0106"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> trial reported that either general or regional anaesthesia was used in the surgery group, and no anaesthesia was required for UGFS (<a href="#CD010878-tbl-0007">Table 5</a>). </p> </section> </section> <section id="CD010878-sec-0107"> <h5 class="title">Duration of procedure</h5> <section id="CD010878-sec-0108"> <h6 class="title">Endovenous ablation therapy versus surgery</h6> <p>All studies reported duration of procedure. However, a meta‐analysis could not be performed because the <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> data recorded mean time without reported standard deviations, and SSV varices data from <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> were not received in time for the analysis. In <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>, the procedure took about one hour (mean time for EVLA was 58.5 minutes compared with 63.6 minutes for surgery) (<a href="./references#CD010878-fig-0010" title="">Analysis 1.7</a>). However, the authors of the <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> trial reported that EVLA was significantly quicker to perform than surgery (21 minutes with EVLA versus 35 minutes with surgery, P &lt; 0.001). The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report results for this outcome separately for people with SSV varices; therefore, results for duration of procedure were not available. </p> </section> <section id="CD010878-sec-0109"> <h6 class="title">Foam sclerotherapy versus surgery</h6> <p>The <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study did not report results for duration of procedure separately for people with SSV varices; therefore, results were not available. </p> </section> </section> </section> <section id="CD010878-sec-0110"> <h4 class="title">Subgroup analysis and sensitivity analysis</h4> <p>It was not possible to perform the planned subgroup analyses, due to a lack of data. Similarly, the sensitivity analyses specified in the protocol could not be undertaken. </p> <p>The only sensitivity analyses that we were able to undertake related to the recanalisation or persistence of reflux at six weeks and the recurrence of reflux at one year in the EVLA versus surgery comparison. In each case, we removed data from the <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> trial from the meta‐analyses, as that trial included participants with GSV varices or SSV varices (or both) and so was underpowered when we analysed only data for participants with SSV varices. When we pooled the results from <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> and <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>, the OR for recurrence of reflux at six weeks was 0.03 (95% CI 0.01 to 0.17; I<sup>2</sup> = 0%, P &lt; 0.0001), which still demonstrates that there were fewer recurrences of reflux for participants who had undergone EVLA, compared to participants who had conventional surgery. When we removed <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> from the meta‐analysis for recurrence of reflux at one year, only <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> contributed data; the OR for <a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> was 0.27 (95% CI 0.07 to 1.06), which did not quite achieve statistical significance (P = 0.06). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010878-sec-0111" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010878-sec-0111">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010878-sec-0152">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010878-sec-0111"></div> <section id="CD010878-sec-0112"> <h3 class="title" id="CD010878-sec-0112">Summary of main results</h3> <section id="CD010878-sec-0113"> <h4 class="title">Endovenous ablation therapy versus surgery</h4> <p>For the primary outcome of recanalisation or persistence of reflux at six weeks after intervention, all three included studies favoured EVLA, and the pooled meta‐analysis demonstrated that there were fewer occurrences of recanalisation or persistence of reflux among the EVLA participants than the surgery participants at six weeks (P &lt; 0.00001). Pooled analysis of two studies suggested that recurrence of reflux was higher at one year in the surgery group compared to EVLA (P = 0.02). Only one study reported clinical recurrence at one year showing no difference between the two treatment groups. Similarly, information about reintervention was limited to one study, with the same percentage in each group requiring further interventional treatment. </p> <p>Only two studies provided data regarding QoL. Although there was no statistically significant difference between the two treatment groups, the mean disease‐specific QoL (AVVQ) scores for participants within each group indicated an improvement over time. Examination of the generic QoL (EQ‐5D) scores showed there was no significant difference between the two treatment groups in the two studies, but in one study the median scores in the surgery group maintained an improvement between six weeks and one year, whereas those scores in the EVLA group began to deteriorate slightly and consistently after six weeks. The second study reported that scores for both groups improved over time. With regard to postoperative pain as measured by VAS, in two studies, it diminished over time for both groups; however, in one study, the EVLA group consistently reported less pain than the surgery group, with the same level of analgesia, during the week immediately following intervention, whereas in the other study, the EVLA group reported a higher level of pain in the first two weeks, but slightly less pain than the surgery group at six weeks. </p> <p>The two studies reported few complications. However, the percentages of participants in each trial that reported neurological complications at six weeks was similar, with complications affecting a larger percentage of the group who had received surgery. One study reported a greater percentage of participants in the surgery group had a wound infection than the other study. </p> <p>All the studies used tumescent anaesthesia for EVLA, and a mixture of general anaesthetic only or general and either regional or spinal anaesthetic for conventional surgery. The duration of the procedure varied between the two studies, which might imply that different end‐points were used; possibly the fact that different anaesthesia was used in the surgery group might account for one group reporting that EVLA was significantly quicker to perform than surgery. Although the studies used different methods to measure participants returning to work, both studies reported that the EVLA group returned to work faster than the surgery group. </p> </section> <section id="CD010878-sec-0114"> <h4 class="title">Foam sclerotherapy versus surgery</h4> <p>There were insufficient data to detect clear differences between the two groups for the outcome recanalisation or persistence of reflux at six weeks, although UGFS did appear to have a potentially lower recurrence rate. However, for reflux recurrence rate at one year, the surgery group appeared to have a slight advantage (again, there were insufficient data to discern a clear difference). There were no data for the other outcomes, as the study authors had not stratified their results by saphenous vein; the trialists expressed willingness to supply the requested data, but this was not received by the time the review was submitted for publication. </p> </section> </section> <section id="CD010878-sec-0115"> <h3 class="title" id="CD010878-sec-0115">Overall completeness and applicability of evidence</h3> <p>This Cochrane Review included three studies; two were designed exclusively for adults with SSV varices (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>), whereas the third was designed for adults with either GSV varices or SSV varices, or both (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>). Two studies included only participants with unilateral varicose veins (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>). The third study included participants with bilateral SSV varices and nominated their worst leg to be their 'study leg' (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>). However, the fact that participants with bilateral SSV varices were included in one trial is likely to be less of a problem for the present review as there were very few participants from that trial with SSV varices, and the trial data available related to recurrence of reflux rather than outcomes that are most likely to be adversely affected by people with bilateral SSV varices, such as QoL, time of duration or return to work. </p> <p>The review describes two of the three prespecified comparisons, but as none of the studies assessed endovenous RFA, it has not been possible to compare this treatment with conventional surgery. </p> <p>Only one trial described UGFS (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>), although all the centres in that trial offered both treatments: thus, there were 21 participants with SSV varices in each treatment group. This is a very small number of participants and the original sample‐size calculation for this comparison estimated a sample size of 770 participants (385 in each group) would be required for at least 90% power at a 5% significance level to detect a change of 0.25 standard deviations in QoL questionnaires. Therefore, any results from this comparison should be viewed as purely exploratory findings and there is a significant potential for type II errors. In addition, many analyses in this study were not stratified according to GSV varices or SSV varices, and therefore data were missing for some outcomes. We contacted the trialists of the <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> study, and they responded positively to our request for data pertaining to participants with SSV varices; however, stratified data had not been received by the time of completion of this review. </p> <p>All three studies described EVLA and conventional surgery, although in the <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> trial only eight of the 11 centres offered EVLA. In this comparison, 311 participants were randomised: 185 participants were treated with EVLA and 126 with conventional surgery. Although the number of participants included in this comparison was not large, it was nevertheless possible to pool the data and perform a meta‐analysis for some outcomes. In one study, data were only available for the first six weeks of follow‐up (<a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>); we contacted the authors and they also responded positively to our request for data up to one year after intervention (according to the study protocol), but data had not been received by the time of completion of this review. It should be noted that final follow‐up for <a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> was six months after intervention, rather than one year; therefore, it is possible that recurrence of reflux in <a href="./references#CD010878-fig-0005" title="">Analysis 1.2</a> is underestimated for this trial. </p> <p>Although not a prespecified outcome of this review, we noted that none of the three included studies reported on neovascularisation, which could be a potential cause of recurrence. </p> </section> <section id="CD010878-sec-0116"> <h3 class="title" id="CD010878-sec-0116">Quality of the evidence</h3> <p>We judged the quality of the evidence in the comparison of EVLA versus conventional surgery to be low to moderate, predominantly because only three studies were included in this review. All the studies were RCTs, and in four of the outcomes, the quality of evidence was downgraded by one level due either to risk of bias (the outcome assessors were not blinded, although some studies had tried to address this problem) or due to imprecision (data were only available from one study for certain outcomes). For three outcomes, the quality of the evidence was downgraded by two levels for risk of bias and either imprecision (for some outcomes data were only available from one small study), or indirectness (since for one study outcome data were only available at six months) (see <a href="./full#CD010878-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>The second comparison, UGFS versus surgery, included only one study and data were only available for two of the primary outcomes. The quality of the evidence for the two outcomes recanalisation or persistence of reflux at six weeks and recurrence of reflux at six months was low: both outcomes were downgraded by one level as only one trial in this review offered UGFS and the study was inadequately powered for SSV varices, and by another level because several of the participants were unaccounted for (for recurrence of reflux at six months, outcomes for 25% of participants (and 33% of participants in the surgery group) were not reported) (see <a href="./full#CD010878-tbl-0002">summary of findings Table 2</a>). </p> </section> <section id="CD010878-sec-0117"> <h3 class="title" id="CD010878-sec-0117">Potential biases in the review process</h3> <p>We undertook extensive searches of databases for studies on SSV varices, and we searched meticulously by hand for reports of trials in reference lists of reviews on varicose veins, health services research‐related resources and abstracts in relevant conference proceedings. We duplicated both the screening of titles, abstracts and full papers, and the assessment of risk of bias and data extraction, and we resolved any disagreements by discussion, to restrict any potential bias. </p> <p>Although all studies included in this review stated that their analyses would be conducted on an ITT basis, which normally uses the number of people who were randomised, in several studies a number of individuals dropped out between randomisation and intervention (in one study because it became apparent that some of the randomised participants were not eligible for inclusion in the trial because of the size of their veins or because they were later discovered to have recurrent varicose veins); in these studies, those participants who actually received interventional treatment were the total number included in the analysis, rather than the number who were initially randomised. </p> <p>Although the three studies predominantly reported most of the same outcomes, in several instances the method used to measure a particular outcome, such as pain or return to work, differed so widely between studies that it was impossible to include the outcome in a meta‐analysis. In such cases, we reported the outcomes in the text and presented results in a table, where appropriate. For one QoL outcome, the EQ‐5D results were so different for one study that we queried whether the same method for calculating the EQ‐5D index had been employed by all the studies, or whether the Dutch and English versions of EQ‐5D were not comparable. We did not pool the results for this QoL outcome in a meta‐analysis, because we believed it would be inappropriate. </p> <p>There were some discrepancies with the definition of certain outcomes among the studies, which is a potential source of bias. For example, the definition of reflux used different thresholds in all three studies: reflux was defined as a retrograde flow of 1 second or more on spectral Doppler after augmentation (<a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a>); greater than 0.5 seconds for incompetence of the superficial venous system (and greater than 0.8 seconds for deep veins) (<a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>); and greater than 1 second (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>). Some outcomes, such as time taken to return to work, were recorded in different ways; although the results for each study have been reported, it has not been possible to pool the data in a meta‐analysis. </p> <p>We noted that studies generally reported absence of reflux as well as recurrence of reflux and we acknowledge that absence of reflux may be an outcome that is easier to interpret and as a consequence this outcome should be included in an update of this review. </p> <p>We contacted the authors of two studies to request further data (<a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a>; <a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a>); in both cases, they agreed in principle, but the data were not available in time to be included in this review. This has resulted in limited analyses being included in this review. </p> </section> <section id="CD010878-sec-0118"> <h3 class="title" id="CD010878-sec-0118">Agreements and disagreements with other studies or reviews</h3> <p>There have been several systematic reviews and meta‐analyses published since the late 2000s: however, most examine either varicose veins in general (<a href="./references#CD010878-bbs2-0032" title="CarrollC , HummelS , LeavissJ , RenS , StevensJW , CantrellA , et al. Systematic review, network meta‐analysis and exploratory cost‐effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins. British Journal of Surgery2014;101:1040‐52. ">Carroll 2014</a>; <a href="./references#CD010878-bbs2-0038" title="LeopardiD , HogganBL , FitridgeRA , WoodruffPWH , MaddernGJ . Systematic review of treatments for varicose veins. Annals of Vascular Surgery2009;23:264‐76. ">Leopardi 2009</a>; <a href="./references#CD010878-bbs2-0040" title="MuradMH , Coto‐YglesiasF , Zumaeta‐GarciaM , ElaminMB , DuggiralaMK , ErwinPJ , et al. A systematic review and meta‐analysis of the treatments of varicose veins. Journal of Vascular Surgery2011;53:49S‐65S. ">Murad 2011</a>; <a href="./references#CD010878-bbs2-0041" title="NelzénO , CervinA , DaxbergE‐L , DrottC , GelinJ , PerssonJ , et al. Endovenous interventions on varicose veins of the leg [Endovenösa interventioner mot åderbråck]. Göteborg: Västra Götalandsregionen, Sahlgrenska Universitetssjukhuset, HTA‐centrum. Regional activity‐based HTA2015; Vol. 77. ">Nelzén 2015</a>), or GSV varices and SSV varices combined (<a href="./references#CD010878-bbs2-0036" title="HogganBL , CameronAL , MaddernJJ . Systematic review of endovenous laser therapy versus surgery for the treatment of saphenous varicose veins. Annals of Vascular Surgery2009;23:277‐87. ">Hoggan 2009</a>; <a href="./references#CD010878-bbs2-0049" title="van denBosR , ArendsL , KockaertM , NeumannM , NijstenT . Endovenous therapies of lower extremity varicosities: a meta‐analysis. Journal of Vascular Surgery2009;49:230‐9. ">van den Bos 2009</a>), or are restricted to GSVs (<a href="./references#CD010878-bbs2-0031" title="BrarR , NordonIM , HinchliffeRJ , LoftusIM , ThompsonMM . Surgical management of varicose veins: meta‐analysis. Vascular2010;18(4):205‐20. ">Brar 2010</a>; <a href="./references#CD010878-bbs2-0039" title="LuebkeT , BrunkwallJ . Systematic review and meta‐analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis. Journal of Cardiovascular Surgery2008;49:213‐33. ">Luebke 2008</a>; <a href="./references#CD010878-bbs2-0047" title="SiribumrungwongB , NooritP , WilasrusmeeC , AttiaJ , ThakkinstianA . A systematic review and meta‐analysis of randomised controlled trials comparing endovenous ablation and surgical intervention in patients with varicose vein. European Journal of Vascular and Endovascular Surgery2012;44:214‐23. ">Siribumrungwong 2012</a>) and do not report findings specifically for SSV varices. To our knowledge the only recent literature review that is restricted to SSV varices is <a href="./references#CD010878-bbs2-0048" title="TellingsSS , CeulenRP , SommerA . Surgery and endovenous techniques for the treatment of small saphenous varicose veins: a review of the literature. Phlebology2011;26(5):179‐84. ">Tellings 2011</a>, which systematically reviewed the literature for papers describing RCTs, non‐randomised controlled trials and all types of observational studies that investigated at least one treatment technique. The authors identified 17 such papers, and calculated the success rate of surgery from four studies (47.8%) and the combined success rate of 10 EVLA studies and two UGFS studies (94.9%) (one identified surgery study could not be used). When <a href="./references#CD010878-bbs2-0048" title="TellingsSS , CeulenRP , SommerA . Surgery and endovenous techniques for the treatment of small saphenous varicose veins: a review of the literature. Phlebology2011;26(5):179‐84. ">Tellings 2011</a> compared the two success rates using the chi‐squared test, the minimally invasive procedures had a statistically higher success rate than surgery (P &lt; 0.001), although there was heterogeneity. We included none of the papers that <a href="./references#CD010878-bbs2-0048" title="TellingsSS , CeulenRP , SommerA . Surgery and endovenous techniques for the treatment of small saphenous varicose veins: a review of the literature. Phlebology2011;26(5):179‐84. ">Tellings 2011</a> identified in our review, but their results are compatible with our outcome of recurrence of reflux, and the percentage of DVT in both groups was similar to that reported in this review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010878-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010878-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010878-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010878-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010878-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010878-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010878-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 1 Recanalisation or persistence of reflux at 6 weeks." data-id="CD010878-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 1 Recanalisation or persistence of reflux at 6 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#CD010878-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010878-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 2 Recurrence of reflux at 1 year." data-id="CD010878-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 2 Recurrence of reflux at 1 year. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#CD010878-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010878-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 3 Recurrence of reflux at 2 years." data-id="CD010878-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 3 Recurrence of reflux at 2 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#CD010878-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010878-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 4 Clinical evidence of recurrence after 1 year." data-id="CD010878-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 4 Clinical evidence of recurrence after 1 year. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#CD010878-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010878-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 5 Disease‐specific QoL (AVVQ) at 6 weeks." data-id="CD010878-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 5 Disease‐specific QoL (AVVQ) at 6 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#CD010878-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010878-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 6 Disease‐specific QoL (AVVQ) at 1 year." data-id="CD010878-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 6 Disease‐specific QoL (AVVQ) at 1 year. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#CD010878-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010878-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 7 Duration of procedure (minutes)." data-id="CD010878-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Endovenous laser ablation (EVLA) versus conventional surgery, Outcome 7 Duration of procedure (minutes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#CD010878-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010878-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Ultrasound‐guided foam sclerotherapy (UGFS) versus conventional surgery, Outcome 1 Recanalisation or persistence of reflux at 6 weeks." data-id="CD010878-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Ultrasound‐guided foam sclerotherapy (UGFS) versus conventional surgery, Outcome 1 Recanalisation or persistence of reflux at 6 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#CD010878-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010878-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/urn:x-wiley:14651858:media:CD010878:CD010878-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_t/tCD010878-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Ultrasound‐guided foam sclerotherapy (UGFS) versus conventional surgery, Outcome 2 Recurrence of reflux at 6 months." data-id="CD010878-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Ultrasound‐guided foam sclerotherapy (UGFS) versus conventional surgery, Outcome 2 Recurrence of reflux at 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#CD010878-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/media/CDSR/CD010878/image_n/nCD010878-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010878-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Endovenous laser ablation compared to conventional surgery for short saphenous vein varices</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Endovenous laser ablation compared to conventional surgery for short saphenous vein varices </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people requiring intervention for short saphenous vein varices </p> <p><b>Setting:</b> hospital day‐case vascular surgery department </p> <p><b>Intervention:</b> EVLA </p> <p><b>Comparison:</b> conventional surgery </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conventional surgery</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with EVLA</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Recanalisation or persistence of reflux at 6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.07<br/> (0.02 to 0.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>289<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1000<br/> (7 to 68) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Recurrence of reflux at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.24<br/> (0.07 to 0.77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>119<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>242 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000<br/> (22 to 197) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical evidence of recurrence after 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.54<br/> (0.17 to 1.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>176 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>104 per 1000<br/> (35 to 273) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reintervention (due to technical failure)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 participants in EVLA group required further treatment: 1 had second EVLA, 3 UGFS</p> <p>4 participants in surgery group required further treatment: 3 had EVLA, 1 ultrasound‐guided perforator ligation </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific QoL (AVVQ) at 6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease‐specific QoL (AVVQ) at 6 weeks was 8.75</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease‐specific QoL at 6 weeks was 8.95</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>265<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference between the disease‐specific QoL (AVVQ) in both groups at 6 weeks was 0.15 (‐1.65 to 1.95). (AVVQ range: 0 = no impact on QoL; 100 = greatest possible impact on QoL) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific QoL (AVVQ) at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease‐specific QoL (AVVQ) at 1 year was 5.3</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease‐specific QoL (AVVQ) at 1 year was 4.22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference between the disease‐specific QoL (AVVQ) at 1 year in both groups was ‐1.08 (‐3.39 to 1.23). (AVVQ range: 0 = no impact on QoL; 100 = greatest possible impact on QoL) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Complications at 6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>265</p> <p>(2 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Main complications reported were sural nerve injury at 6 weeks (11/161 EVLA; 30/104 surgery), wound infection; 2 cases of DVT (1e in each group). See <a href="#CD010878-tbl-0006">Table 4</a> for detailed information </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AVVQ:</b> Aberdeen Varicose Veins Questionnaire; <b>CI:</b> confidence interval; <b>EVLA:</b> endovenous laser ablation; <b>OR:</b> odds ratio; <b>QoL:</b> quality of life; <b>RCT:</b> randomised controlled trial; <b>UGFS:</b> ultrasound‐guided foam sclerotherapy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to risk of bias: limitation of power in one study, and a 2:1 EVLA:surgery allocation that did not appear to be prespecified in another study.<br/> <sup>2</sup> Downgraded one level due to risk of bias and one level for potential concerns relating to imprecision and indirectness, since one study reported outcomes at six months rather than one year.<br/> <sup>3</sup> Downgraded one level for risk of bias and one level for imprecision (n = 99).<br/> <sup>4</sup> Downgraded one level for imprecision (n = 99).<br/> <sup>5</sup> Downgraded one level for risk of bias. Decision taken not to downgrade for imprecision because the mean difference between the two treatments was negligible on the total AVVQ range (0 to 100).<br/> <sup>6</sup> Downgraded one level for imprecision in one study. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Endovenous laser ablation compared to conventional surgery for short saphenous vein varices</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010878-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Ultrasound‐guided foam sclerotherapy compared to conventional surgery for short saphenous vein varices</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Ultrasound‐guided foam sclerotherapy compared to conventional surgery for short saphenous vein varices </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people requiring intervention for short saphenous vein varices </p> <p><b>Setting:</b> hospital day‐case vascular surgery department </p> <p><b>Intervention:</b> UGFS </p> <p><b>Comparison:</b> conventional surgery </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conventional surgery</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with UGFS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Recanalisation or persistence of reflux at 6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.34<br/> (0.06 to 2.10) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>33<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>294 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>124 per 1000<br/> (24 to 467) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Recurrence of reflux at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.19<br/> (0.29 to 4.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>31<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Follow‐up for this outcome was only available for 6 months in this trial</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>429 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>472 per 1000<br/> (179 to 787) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical evidence of recurrence after 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical evidence not stratified by GSV/SSV</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reintervention (due to technical failure)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reintervention not stratified by GSV/SSV</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific QoL (AVVQ) at 6 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>QoL not stratified by GSV/SSV</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific QoL (AVVQ) at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>QoL not stratified by GSV/SSV</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Complications at 1 year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Complications not stratified by GSV/SSV</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AVVQ:</b> Aberdeen Varicose Veins Questionnaire; <b>CI:</b> confidence interval; <b>GSV:</b> great saphenous vein; <b>OR:</b> odds ratio; <b>QoL:</b> quality of life; <b>RCT:</b> randomised controlled trial; <b>SSV:</b> short saphenous vein; <b>UGFS:</b> ultrasound‐guided foam sclerotherapy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for imprecision (only one trial in this review offered UGFS) and one level for limitation in design as the study was inadequately powered for participants with SSV varices alone. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Ultrasound‐guided foam sclerotherapy compared to conventional surgery for short saphenous vein varices</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010878-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Disease‐specific quality of life scores (AVVQ) over follow‐up: EVLA versus surgery</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Time point</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. "><b>HELP 2</b> </a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. "><b>VESPA</b> </a> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>AVVQ scores (mean (SD))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>P value<sup>§</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>AVVQ scores (mean (SD))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>P value<sup>§§</sup> </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>EVLA</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgery</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>EVLA</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgery</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.2 (6.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.5 (6.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.215</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.0 (10.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.9 (5.9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.2 (6.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.9 (6.4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.092</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.8 (7.7)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.4 (8.9)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8 (7.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8 (5.5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.996</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.0 (7.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.7 (8.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1 (4.9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.2 (5.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.787</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2 (6.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3 (5.7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.327</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>*These scores were measured at 2 weeks after the procedure'<br/> <sup>§</sup>Student <i>t</i>‐test for intergroup analysis'<br/> <sup>§§</sup>Individual P values were not reported, but the authors reported there were no significant differences between the groups (P &lt; 0.001). </p> <p>AVVQ: Aberdeen Varicose Veins Questionnaire; EVLA: endovenous laser ablation; nr: not recorded. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Disease‐specific quality of life scores (AVVQ) over follow‐up: EVLA versus surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010878-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Generic quality of life scores (EQ‐5D) over follow‐up: EVLA versus surgery</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Time point</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. "><b>HELP 2</b> </a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. "><b>VESPA</b> </a> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>EQ‐5D (median (IQR))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>P value</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>EQ‐5D (mean (SD))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>P value</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>EVLA</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgery</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>EVLA</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgery</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81 (0.73 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 (0.80 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.249</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.19)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.19 (0.19)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80 (0.70 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.77 (0.69 to 0.88)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.256</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20 (0.22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.13)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.84 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.81 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.802</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.09 (0.16)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 (0.16)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 (0.76 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.85 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.095</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.93 (0.78 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0 (0.81 to 1.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.119</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nr</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>EQ‐5D EuroQoL 5‐Dimension; EVLA Endovenous laser ablation; nr: not recorded.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Generic quality of life scores (EQ‐5D) over follow‐up: EVLA versus surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010878-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Generic quality of life scores (SF‐36) over follow‐up: EVLA versus surgery</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>SF‐36 domain</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Time point</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. "><b>HELP 2</b> </a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EVLA (median (IQR))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgery (median (IQR))</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>P value</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Physical functioning</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (70 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.891</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 (61 to 95)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (50 to 90)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.095</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (85 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.708</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (80 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (85 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.766</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (78 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95 (85 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.896</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Role physical</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (50 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (50 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.969</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 (0 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 (0 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.277</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (31 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (25 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.644</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (50 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.779</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.502</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Bodily pain</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 (51 to 84)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 (42 to 88)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.826</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62 (41 to 84)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 (41 to 74)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.325</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (62 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 (54 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.469</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (62 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (62 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.483</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (62 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (62 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.280</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>General health</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (53 to 84)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (52 to 87)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.606</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (56 to 82)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (53 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.341</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (57 to 89)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82 (67 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.175</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75 (62 to 87)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 (65 to 91)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.403</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 (57 to 87)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82 (67 to 93)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.077</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Vitality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 (46 to 75)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65 (50 to 80)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.072</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (45 to 74)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 (45 to 74)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.690</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68 (45 to 80)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (60 to 85)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.325</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (45 to 80)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (50 to 80)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.774</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65 (50 to 75)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75 (54 to 85)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.136</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Social functioning</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.420</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88 (63 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75 (50 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.082</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (63 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.198</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.877</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (78 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.364</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Role emotional</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (75 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.820</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (67 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.498</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.582</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (67 to 100)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.155</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.510</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Mental health</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78 (60 to 87)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 (72 to 88)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.167</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78 (65 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (68 to 91)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.680</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 (68 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (76 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.369</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 (72 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88 (74 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.456</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 (68 to 90)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88 (72 to 92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.071</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>EVLA: endovenous laser ablation; SF‐36: 36‐Item Short Form Health Survey.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Generic quality of life scores (SF‐36) over follow‐up: EVLA versus surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010878-tbl-0006"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Postprocedural complications: EVLA versus surgery</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b> Complication</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b> Treatment group</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. "><b>HELP 2</b> </a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. "><b>VESPA</b> </a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> n</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> %</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> n</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> %</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>DVT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/110</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Thermal injury</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Sural nerve injury at 6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/51</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/110</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Sural nerve injury at 52 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Wound infection</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Haematoma</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pigmentation/skin bruising</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/51</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Phlebitis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/51</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/52</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nr</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>DVT: deep venous thrombosis; EVLA: endovenous laser ablation; n: number of participants; nr: not reported. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Postprocedural complications: EVLA versus surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010878-tbl-0007"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Type of anaesthesia</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type of anaesthesia</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD010878-bbs2-0001" title="BrittendenJ . Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins (ISRCTN 51995477). www.controlled‐trials.com/ISRCTN51995477 Date first received: 25 February 2008. BrittendenJ , CottonSC , EldersA , RamsayCR , NorrieJ , BurrJ , et al. A randomized trial comparing treatments for varicose veins. New England Journal of Medicine2014;371(13):1218‐27. BrittendenJ , CottonSC , EldersA , TassieE , ScotlandG , RamsayCR , et al. Clinical effectiveness and cost‐effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment (Winchester, England)2015;19(27):1‐341. ISRCTN51995477 . The CLASS study. Comparison of LAser, Surgery and foam Sclerotherapy. Research protocol (Protocol 09PRT/2275; EudraCT 2008‐001069‐26) Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins. NIHR Health Technology Assessment Programme www.nets.nihr.ac.uk/__data/assets/pdf_file/0004/51448/PRO‐06‐45‐02.pdf (accessed 12 July 2016). TassieE , ScotlandG , BrittendenJ , CottonSC , EldersA , CampbellMK , et al. Cost‐effectiveness of ultrasound‐guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery2014;101:1532‐40. ">CLASS</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local tumescent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>General or regional</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UGFS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010878-bbs2-0002" title="ISRCTN56883670 . EVLT for sapheno‐popliteal incompetence and SS reflux: a RCT. www.isrctn.com/ISRCTN56883670 Date first received: 29 September 2006. NCT00841178 . Endovenous laser therapy (EVLT) for sapheno‐popliteal incompetence and short saphenous vein (SSV) reflux: a RCT. clinicaltrials.gov/ct2/show/NCT00841178 Date first received: 10 February 2009. NandhraS , El‐SheikhaJ , CarradiceD , WallaceT , SouroullasP , SamuelN , et al. A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Journal of Vascular Surgery2015;61(3):741‐6. SamuelN , CarradiceD , MekakoAI , WallaceT , HatfieldJ , ChetterIC . Randomised trial of endovenous laser ablation versus surgery for small saphenous varicose veins. The Vascular Society of Great Britain &amp; Ireland Yearbook 20112011:82. SamuelN , CarradiceD , WallaceT , MekakoA , HatfieldJ , ChetterI . Randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins. Annals of Surgery2013;257(3):419‐26. ">HELP 2</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local tumescent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>General</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010878-bbs2-0003" title="NTR1554 . VESPA trial: endovenous laser treatment versus crossectomy of the small saphenous vein. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1554 Date first received: 24 November 2008. RoopramAD , LindMY , vanBrusselJP , Terlouw‐PuntLC , BirnieE , DeSmetAA , et al. Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders2013;1(4):357‐63. ">VESPA</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EVLA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local tumescent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>General or spinal</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>EVLA: endovenous laser ablation; UGFS: ultrasound‐guided foam sclerotherapy.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Type of anaesthesia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/full#CD010878-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010878-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Endovenous laser ablation (EVLA) versus conventional surgery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recanalisation or persistence of reflux at 6 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>289</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.02, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recurrence of reflux at 1 year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.07, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Recurrence of reflux at 2 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Clinical evidence of recurrence after 1 year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Disease‐specific QoL (AVVQ) at 6 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [‐1.65, 1.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Disease‐specific QoL (AVVQ) at 1 year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Duration of procedure (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Endovenous laser ablation (EVLA) versus conventional surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#CD010878-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010878-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Ultrasound‐guided foam sclerotherapy (UGFS) versus conventional surgery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recanalisation or persistence of reflux at 6 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recurrence of reflux at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Ultrasound‐guided foam sclerotherapy (UGFS) versus conventional surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010878.pub2/references#CD010878-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010878.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010878-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010878-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="ru#CD010878-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010878\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010878\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010878\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010878\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010878\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010878.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010878.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010878.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010878.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010878.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718134092"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010878.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718134096"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010878.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dc8eb7981f3fd',t:'MTc0MDcxODEzNC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 